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1.1 Background 
 
Semiconductor materials are at the core of modern civilisation. They can be found 
in most electronic devices, being the constituents of transistors, light emitting diodes, solar 
cells and so on. The earliest days of semiconductor research date back to 1833 when 
Michael Faraday published his observation on the electrical conduction by silver sulfide 
(Ag2S) [1]. The latter part of the 19th century and early years of 20th century saw a sedate, 
yet relentless progress in the field. And then the invention of the transistor in 1947 set up a 
precedent which led to a technological revolution. Research on semiconductor nanocrystals 
was triggered in the early 1980s when Alexei Ekimov observed size dependent optical 
properties of CdS particles in a glass matrix and Louis Brus in colloidal CdS [2]. 
Initially there was scepticism on whether these materials chemically synthesised in flask 
could ever compete or even complement with what was being produced by physical 
techniques in vacuum chambers. But with the advent of high quality synthetic schemes 
over last two decades [3-8], colloidal semiconductor nanocrystals are being investigated to 
foster their use in various technologically and economically important fields such as 
photovoltaics, solid state lighting, biological labeling, etc.  
 
1.2 Colloidal semiconductor nanocrystals: quantum dots  
 
1.2.1 Definition 
 
Colloidal semiconductor nanocrystals (NCs) also known as quantum dots (QD) [9] 
are crystalline particles of a diameter typically ranging from 1 to 10 nm. Due to their small 
size which approaches molecular dimensions they have discrete electronic energy levels 
and size-dependent optical and electrical properties. They are chemically synthesized in 
form of colloids by restricting the growth of the crystal at an early stage. Usually organic 
surfactants or ligands are used to stabilize the NCs in colloidal solution.  
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1.2.2 Properties of quantum dots 
 
1.2.2.1 Quantum confinement effect 
 
When an electron is excited from the valence band to the conduction band in a 
semicondutor, it leaves behind a positively charge vacancy known as hole. In bulk 
semiconductors, the electron-hole pair is bound within a characteristic length referred to as 
exciton Bohr radius ( Br ), which is given by the equation 1.1 
⎟⎟⎠
⎞
⎜⎜⎝
⎛ += ∗∗
he
r
B mme
r 112
εh
                                                                                                     1.1 
where ∗em  and 
∗
hm  are the effective masses of electron and hole respectively and rε  is the 
relative dielectric constant of the medium. When the size of the semiconductor particle 
approaches the exciton Bohr radius, spacial confinement of the electrons and holes occurs 
which results in discrete atomic like energy spectra (Fig.1.1). In quantum dots, which are 
nearly spherical semiconductor NCs, the confinement occurs in all three dimensions. One 
of the interesting consequences of this discretisation of energy levels is that semiconductor 
NCs exhibit size dependent electronic and optical properties properties.  
 
  
 
Fig 1.1 Scheme of the electronic levels in a single atom, a molecule, a quantum dot and a bulk 
semiconductor (example silicon) [10, 11].  
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The size dependency of the band gap is the most prominent effect of quantum confinement. 
To a first approximation, the band gap gE  of nanocrystals of radius r is given by the 
following equation 1.2 [12]  
 
r
e
mmr
EE
rhe
bulk
gg
1786.1
*
1
*
1
2 0
2
2
22
εε
π −⎟⎟⎠
⎞
⎜⎜⎝
⎛ ++= h                                                            1.2 
 
where the first term, bulkgE  on left hand side of the equation is the band gap of the bulk 
material when r is infinitely large. The second term corresponds to the sum of the single 
particle ground state energies. When r  is much smaller than Br  , the material is often said 
to be in “strong confinement regime” [13] as opposed to “weak confinement regime” when 
r  slightly smaller than Br . From equations 1.1 and 1.2, the correlation between the band 
gap, exciton Bohr radius and the radius of the NCs can be obtained (equation 1.3).  
 
⎟⎠
⎞⎜⎝
⎛ −×+= 174.2
6.2
r
r
r
EE B
r
bulk
gg ε                                                                                      1.3 
 
Here gE and 
bulk
gE  are expressed in eV and Br  and r in nm. It is thus evident that various 
semiconductor materials with a wide range of energy gaps cover a wide spectral range from 
the near infrared to the near ultraviolet. Therefore, for specific application the knowledge of 
the band gap as a function of particle size is important. Table 1.1 gives the parameters at 
room temperature for several II-VI, III-V and IV-VI semiconductors. 
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Material Structure 
(300K) 
Type Egap (eV) Lattice 
parameter 
(Å) 
Density 
(kg/m3) 
ZnS Zinc-blende II-VI 3.61 5.41 4084 
ZnSe Zinc-blende II-VI 2.69 5.668 5266 
ZnTe Zinc-blende II-VI 2.39 6.104 5636 
CdS Wurtzite II-VI 2.49 4.136/6.714 4820 
CdSe Wurtzite II-VI 1.74 4.3/7.01 5810 
CdTe Zinc-blende II-VI 1.43 6.482 5870 
GaN Wurtzite III-V 3.44 3.188/5.185 6095 
GaP Zinc-blende III-V 2.27 5.45 4138 
GaAs Zinc-blende III-V 1.42 5.653 5318 
GaSb Zinc-blende III-V 0.75 6.096 5614 
InN Wurtzite III-V 0.80 3.545/5.703 6810 
InP Zinc-blende III-V 1.35 5.869 4787 
InAs Zinc-blende III-V 0.35 6.058 5667 
InSb Zinc-blende III-V 0.23 6.479 5774 
PbS Rocksalt IV-VI 0.41 5.936 7597 
PbSe Rocksalt IV-VI 0.28 6.117 8260 
PbTe Rocksalt IV-VI 0.31 6.462 8219 
 
Table 1.1 Parameters of selected semiconductors [14] 
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1.2.2.2 Optical properties 
 
1.2.2.2.1 Absorption 
 
 In a direct band gap semiconductor, the absorption of a photon with energy greater 
than the band gap promotes an electron from the valence band to the conduction band, 
creating an electron hole pair (exciton). The exciton state with the lowest energy appears as 
a peak or distinct hump in an absorption spectrum of the NCs sample. This peak often 
referred to as first excitonic peak has an energy slightly lower energy than the band gap 
energy of the sample due to the contribution of coulomb attraction. The band gap is the 
energy required to create and electron (e-) and the hole (h+) at rest with the lattice and far 
apart enough so that the coulomb attraction is 
negligible [15]. The position of the excitonic peak 
depends on the band gap of the material as well as the 
size of the NCs. Due to quantum confinement the 
increase of NCs’ size leads to the red-shift of the 
absorption onset. Another unique property of 
quantum dots is that their absorbance increases in the 
blue region. Consequently, the quantum dots can be 
excited in a wide range of wavelengths which give an 
advantage over organic dyes. Those generally have 
narrow absorption spectra and limited window of 
wavelength is available for the excitation of 
fluorescence.  
 
 
Figure 1.2 Size-dependent evolution of the UV-Vis absorption spectra of InP NCs [16]. 
 
1.2.2.2.2 Photoluminescence 
 
After the absorption of a photon by the NC, leading to the formation of an exciton, the 
system can relax to the ground state by radiative recombination of the electron-hole pair. 
Radiative decay through emission of photons is called photoluminescence or more 
specifically in the case of QDs fluorescence. The emission efficiency of QDs is expressed 
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in terms of the fluorescence quantum yield (QY), which is the ratio between the number of 
absorbed photons and the number of emitted photons. The room temperature 
photoluminescence of the NCs is often poor due to the surface defects which cause non-
radiative desexcitation channels [17]. The surface to volume ratio of NCs is much higher 
than in their bulk counterparts. For example, for 5 nm CdS, about 30% of the atoms are on 
the surface. Although surface passivation can be achieved to some extent using appropriate 
ligands [5], the most commonly employed and successful way of surface passivation is the 
epitaxial growth of another material around the NCs forming core/shell structure [14]. The 
shell plays a multiple role including surface passivation, protection of the core from 
oxidation and degradation. Due to the improved passivation of surface trap states, the 
fluorescence quantum yield is generally strongly increased by the shell growth.  
 
 
 
 
Figure 1.3 Size-dependent photoluminescence properties of InP NCs synthesised in thesis. A) 
Photograph showing different sized NCs under UV light B) corresponding PL spectra (self prepared 
samples).  
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1.2.2.3 Crystal structure 
 
Zinc-blende and wurtzite are the most common crystal structuresrelized by bulk II-VI and 
III-V semiconductors (Figure 1.4). Zinc blende is based on a face centred cubic (FCC) 
lattice of anions whereas wurtzite is derived from hexagonal close packing (hcp) array of 
anions. Both structures have tetrahedrally coordinated atoms. Some semiconductors (e.g. 
ZnS, CdTe, ZnSe) are known to exhibit both types of crystals structures (known as 
polytypes) [18]. The general perception is that the semiconductor NCs exhibits the same 
crystal structure as in bulk. However, some reports suggest that the reaction parameters, 
nature of ligands and size of the NCs could well influence the crystalline nature and even 
the lattice structure of the NCs. For example, ZnS transforms from zinc-blende to a rocksalt 
phase at 15.4 GPa. The transition pressure remains constant upon decreasing particle size 
to 15 nm. Below 15 nm, this phase transformation occurs at an elevated pressure [19]. A 
similar size dependent effect on the crystal structure has been observed in CdSe NCs [20].   
 
 
Figure 1.4: a) Zinc blende b) wurtzite crystal structure. 
 
1.2.3 Synthesis of colloidal semiconductor NCs 
 
The observation of the quantum size effect in nanometer sized colloidal CdS in the early 
1980s [12, 15] gave the scientific community an impetus to synthesize and study colloidal 
NCs.  Initially, these NCs were prepared in aqueous medium [21] as well as reverse 
micelles [22]. High boiling coordinating solvents were introduced for the synthesis of NCs 
in 1989 [23]. A real breakthrough came when Murray et al. reported highly crystalline and 
nearly monodiserse (size distributions of 8–11%) CdS, CdSe and CdTe NCs in 1993 [3]. 
They used a mixture of trioctylphosphine (TOP) and trioctyl phosphine oxide (TOPO) as 
high boiling point solvent/ligand. As demonstrated in classical studies by LaMer and 
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Dinegar [24], the synthesis of monodisperse colloids via homogeneous nucleation requires 
the temporal separation of nucleation and growth of the seeds. The mechanism and 
formation of mondispersed colloidal NCs can be explained using LaMer plot [24]. 
  
 
 
Fig. 1.5. LaMer plot depicting the degree of supersaturation as a function of reaction time 
 
Initially the concentration of monomers, i.e. the minimum subunits of the crystal existing in 
solution, constantly increases by addition from exterior or by in situ generation within the 
reaction medium. It should be noted that in stage I no nucleation occurs even in 
supersaturated solution (S>1), due to the extremely high energy barrier for spontaneous 
homogeneous nucleation. The latter is overcome in Stage II for a yet higher degree of 
supersaturation (S>Sc), where nucleation and formation of stable nuclei take place. As the 
rate of monomer consumption induced by the nucleation and growth processes exceeds the 
rate of monomer supply, the monomer concentration and hence the supersaturation 
decreases below SC, the level at which the nucleation rate becomes zero. In the following 
stage III, the particle growth continues under further monomer consumption as long as the 
system is in the supersaturated regime. 
Experimentally, the separation of nucleation and growth can be achieved by rapid injection 
of the reagents into the hot solvent, which raises the precursor concentration in the reaction 
flask above the nucleation threshold (“hot-injection method”) [25]. The hot injection leads 
to an instantaneous nucleation, which is quickly quenched by the fast cooling of the 
reaction mixture (the solution to be injected is at room temperature) and by the decreased 
supersaturation after the nucleation burst. Another possibility relies on attaining the degree 
of supersaturation necessary for homogeneous nucleation via the in situ formation of 
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reactive species upon supply of thermal energy (heating-up method) [26]. This method is 
widely used in the synthesis of metallic nanoparticles, but recently an increasing number of 
examples of semiconductor NCs prepared by this approach can be found. In an ideal case 
all crystallization nuclei are created at the same time and undergo identical growth. During 
the growth stage it is possible to carry out subsequent injections of precursors in order to 
increase the mean particle size without deterioration of the narrow size distribution as long 
as the concentration corresponding to the critical supersaturation Sc is not exceeded. Crystal 
growth from solution is in many cases followed by a second distinct growth process, which 
is referred to as Ostwald ripening [27]. It consists of the dissolution of the smallest particles 
because of their high surface energy and subsequent redeposition of the dissolved matter 
onto the bigger ones. Thereby the total number of NCs decreases, whereas their mean size 
increases. As shown in early studies [28], Ostwald ripening can lead to reduced size 
dispersions of micron-sized colloids. In the case of nanometer-sized particles, however, 
Ostwald ripening generally yields size dispersions of the order of 15-20%, and therefore the 
reaction should be stopped before this stage [29] . 
 
1.2.4 Core/shell nanocrystals 
 
The photoluminescence efficiency of the as-synthesized NCs is not sufficient for 
biological imaging application. This is true for all types of NCs including the highly studied 
CdSe systems. Generally, over-coating the nanocrystallites of one material with another 
inorganic material with larger band gap is a common mode of improving the PL efficiency 
of the material by passivating the surface related non-radiative recombination sites. They 
are commonly referred to as core/shell NCs. Some selected examples of such luminescent 
core/shell systems are CdSe/ZnS NCs [4, 30], CdSe/CdS NCs [31], CdSe/ZnSe [7], 
PbSe/PbS [32], InAs/ZnSe [33], InP/ZnCdSe2 [34] and InP/ZnS [35]. Two important 
parameter for the synthesis of core/shell NCs are a) the band alignment which is the relative 
position of the conduction and valence band of the two materials in energy scale and b) the 
crystal structures or more precisely the lattice parameters of the core and shell materials.  
Depending on the band alignment of the core and shell materials, the NCs can be type I or 
type II [14]. In a type I core/shell system the conduction band edge of the shell (the higher 
band gap material) is of higher energy than that of the core (the lower band gap material), 
and the valence band edge of the shell has lower energy than that of the core. 
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Consequently, both electrons and holes are confined in the core. In a type-II QD in contrast, 
both the valence and conduction band edges in the core are situated below or above lower 
(or higher) than in the shell. As the only one carrier is confined to the core, while the other 
is confined to the shell, the photoluminescence emission of the type II systems are red 
shifted. As a result, much longer emission wavelengths are accessible with materials which 
otherwise emit in the shorter wavelengths. Some examples of such system are CdTe/CdSe 
[36], CdSe/ZnTe [36], ZnTe/ZnSe [37]. 
 
1.3 Quantum dots in biology 
 
1.3.1 Aqueous solubility  
 
The possibility to disperse NCs in aqueous medium is a fundamental criterion for 
application of these NCs in biology. QDs prepared in organic solvents have no intrinsic 
aqueous solubility as they are stabilised by ligands containing long hydrophobic alkyl 
chains. Usually a phase transfer step is involved before these NCs are solubilized in 
aqueous medium. A large number of methods for phase transfer involve the exchange of 
surface ligands on the NCs by hydrophilic molecules. One of the first reported methods 
involves exchange of surface ligands with hydrosoluble mercaptoacetic acid [38]. The thiol 
group and even more its deprotonated thiolate form, has high affinity for atoms like Zn in 
the ZnS shell resulting in strong binding. Consequently, thiol containing ligands have been 
widely used for the preparation of hydrophilic QDs. Some commonly used thiol group 
containing ligands include mercaptocarboxylic acids, amino acids such as cysteine [39], 
dihydrolipoic acid derivatives [40] and peptides [41, 42]. In addition, phospholipid micelles 
[43] and  amphiphilic polymers [44] have also been used as phase transfer agents. In this 
case, no exchange of the original surface ligands is carried out, but the amphiphilic 
molecules “stick” to the surface  by hydrophobic interactions involving their apolar groups. 
Their polar moieties point to the exterior, giving hydrosolubility and stability to the QDs. 
On the other hand, the hydrodynamic diameter is strongly increased to around 15-25 nm 
upon encapsulation with amphiphilic molecules. For in vivo studies such large 
hydrodynamic diameters are obstacle for renal clearance [45]. In the case of ligand 
exchange, however, the loss of fluorescence is a major concern. In this thesis the problem 
of fluorescence reduction during the aqueous transfer processes of NCs using ligand 
exchange will be addressed. 
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1.3.2 Bioconjugation 
Since the first studies in 1998 showing that organically prepared quantum dots can 
be solubilised in water and then be used as fluorescent labels in biology [38, 46], a large 
number of functional molecules such as proteins, nucleotides, peptides, small molecules, 
drugs, genes etc. have been bioconjugated with QDs and various studies performed. There 
are various ways of attaching biomoleucles to NCs. Some of them include direct ligand 
exchange with thiol group containing biomolecules, the use of cross-linkers, use of 
coupling agents and electrostatic. Thiol groups containing biomolecules such cysteine rich 
peptides rely on the affinity of thiols to cationic sites on the NPs surface and are directly 
attached to the surface of the QDs [47, 48].  Bifunctional cross linkers such as 4-(N-
maleimidomethyl) cyclohexane-1-carboxylate (SMCC), which contain both thiol reactive 
maleimide group and amino reactive N-hydrosuccinimide can be used if the quantum dots 
have free thiols or amines on the surface.  Coupling agents such as carbodiimide are used to 
covalently link free carboxylic groups on the surface of conjugation and the amine group 
on of the biomolecules. Conjugation has also been achieved by means of electrostatic 
attraction between positively charged proteins and negatively charged lipoic acid capped 
CdSe/ZnS QDs [49].  
1.3.3 Cellular labeling 
 
One of the current interests of QDs lies in developing probes for imaging inside 
living cells. Intracellular application can be more challenging than extracellular target 
recognition. The first challenge is to cross the plasma membrane without being engulfed by 
living cells through a nonspecific uptake mechanism. Second, reaching the specific 
intracellular targets may be complicated by the presence of a variety of proteins, nucleic 
acids and other molecules in cytoplasm that may potentially bind to the QDs or the 
biomolecules on their surface, resulting in aggregation. Some reported methods used for 
intracellular delivery of quantum dots are a) Transfection – QDs are delivered into cells via 
artificially prepared vesicles made of lipid bilayers (called liposomes) [50, 51] b) 
Electroporation – QDs are delivered by increasing the electrical conductivity and the 
permeability of the cell membrane using an external electrical field [52] c) Microinjections 
[43, 51] d) Using cell penetrating peptides –peptides which can translocate into the cell 
carrying a cargo [53]. This cargo may vary from small drug molecules to QDs.  
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1.3.4 In vivo near infrared (NIR) fluorescence imaging  
 
Given the versatility of the QDs surface for bioconjugation, the possibility of application is 
enormous. For example, QDs can be labeled with tumour-targetting antibodies and traced 
with fluorescence imaging techniques or can be employed in tracking cancer cells in 
metastasis [54, 55]. However, the efficiency of a fluorescence based probe in biomedical 
imaging highly depends on the fate of the photons propagating in and out of the living 
tissue. The loss of photon signal occurs through absorption and scattering by living tissues. 
In addition, the tissue auto-fluorescence (which can result from the absorption of photons 
by tissue components) substantially decreases the contrast between the target and the 
background. While scattering is either inversely proportional to a certain power of 
wavelength (e.g. 2.8 for rat skin) or nearly independent of the wavelength (e.g. 0.6 human 
breast) [56], the absorption by living tissues are relatively low in near infrared region (650-
900 nm) of the spectrum [57]. This includes even the major absorbers of visible and NIR 
light, haemoglobin and water (Fig. 1.6). In fact, this window is bordered by increasing 
absorbance of blood (haemoglobin) on one side (<650nm), and by high absorbance of 
water on the other (>900nm) [58]. This makes an NIR (650-900 nm) emitting fluorescent 
probes ideal candidates for use in tissue imaging with increased penetration depth. 
 
 
Fig 1.6   Absorption coefficient of two major light absorbers depending on wavelengths [57]. 
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1.4 NIR emitting quantum dots 
 
CdSe based NCs have been the most widely studied colloidal NCs. High crystallinity, 
shape and size control, and fluorescence quantum yields close to 100 % in organic solvents 
have been achieved [7, 31, 59].   However, due to relatively large band gap (bulk band 
gap:  1.74 eV at 300°K), the maximum PL emission achieved for CdSe NCs is around 650 
nm.  For in vivo imaging application in NIR, this might not be sufficient. Many other 
semiconductor NCs with smaller band gaps have been successfully synthesized to access 
NIR emission (Fig. 1.7). Recently in addition to II-IV and III-V, II-V semiconductor NCs 
emitting in NIR wavelengths have also been reported (e.g. Cd3P2 and Cd3As2) [60, 61]. In 
addition, the type II core/shell structures have also been synthesized to get access to NIR 
wavelengths. For example, NIR emitting CdTe/CdSe type II core/shelll NCs have been 
successfully applied to image lymph nodes present deep (up to 1 cm) in tissues [62]. 
Another example of NIR emitting NCs in biology is the use of InAs NCs for successful 
imaging tumor vasculature [63]. However, most of these NCs involve elements of highly 
restricted use like Cd, As, Hg (cf. Table 1.2). As an alternative InP based NCs (bulk band 
gap: 1.35 eV) are seen as a promising candidate for in vivo NIR imaging. 
 
Figure 1.7 Emission wavelengths as a function of QD diameter for various semiconductors. Inset: 
normalized PL spectra [64]. 
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Details Type I Type II 
QD CdTe InP Cd3P2 PbS InAs Cd3As2 HgTe CdTe/CdSe 
Bulk band   
gap (eV) 
1.43 1.35 0.55 0.41 0.35 0.19 0* NA 
Reference [65, 
66] 
[6, 67, 
68] 
[60] [69] [63] [61] [70, 
71] 
[36, 72] 
 
Table 1.2 Various types of NIR emitting NCs. *Bulk HgTe is a semimetal. 
 
 
1.4.1 Indium phosphide (InP) NCs  
 
InP is a low band gap (bulk value: 1.35 eV) III-V semiconductor with a exciton 
Bohr’s radius of 11.5 nm. In the strong quantum confinement regime its photoluminescence 
can be tuned from blue to the near infrared (NIR) by varying the size. As discussed in the 
previous section, NIR emitting QDs are particularly interesting for in vivo imaging, due to 
the better transparency of tissues in this region of the electromagnetic spectrum [57]. In 
addition, the absence of highly toxic elements like cadmium, arsenic, lead and mercury 
makes InP based luminescent probes highly attractive for biological imaging applications. 
To realise the full potential of InP NCs in biotechnonology the first  requirement is to 
develop a robust method for synthesising larger sized InP NCs with emission >700 nm. The 
InP NCs can then be processed into core/shell systems [34] to improve their PL QY,  
photo- and chemical stability. Traditionally, the synthesis of III-V semiconductor QDs is 
considered more difficult than their II-VI counterparts (e.g. CdSe, CdTe, ZnS) due to the 
more covalent nature of bonds [73]. The majority of the existing routes for the synthesis of 
InP colloidal nanocrystals (NCs) found in literature are based on Well’s dehalosilylation 
reaction [74] first adapted by Micic et al [75] for colloidal InP NCs. In this reaction 
[(CH3)3Si]3P is reacted with an indium (III) precursor at elevated temperatures (180-300°C) 
in a high boiling solvent and invariably in presence of a stabilising ligand (e.g. fatty acids 
[8], amines [6, 68] and/or the alkyl phosphine [73]). This synthetic approach has brought a 
major success in recent times in the synthesis of high quality InP/ZnS NCs  with quantum 
yields nearly comparable to CdSe based NCs [6, 76]. However, as far as red or NIR 
emitting (>700 nm) InP NCs or related core/shell structures (e.g. InP/ZnS)  are concerned 
although the successful preparation of emitting QDs is acclaimed, no experimental details 
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are given [6, 68]. Larger sized NCs are typically synthesised via multiple injections of 
precursor solutions to the solution of smaller InP NCs at high temperatures [6, 67], often 
followed by a size selective precipitation step [67]. The longest emission reported for InP 
NCs by this method is ~750 nm [6, 67]. Another way of synthesising InP NCs is using 
phosphine gas as the phosphorous precursor [77]. In this method, the in situ generated 
phosphine gas is reacted with the indium precursor in the presence of a ligand at high 
temperature (210°C to 290°C). Since the PH3 gas is slowly and continuously bubbled into 
the flask containing the precursor solutions, similar to the aforementioned multiple 
injection method, the overall size is expected to be larger. In the frame of this thesis, we 
focus on exploring this last method with the goal to push the emission wavelength as far as 
possible to the NIR. 
 
1.5 Motivation 
As summarized above in the state-of-the-art (Chapter I), QDs are promising 
fluorescent labels for biological imaging, due to their size-dependent emission properties, 
pure emission colors, high absorption coefficient and fluorescence quantum yield (resulting 
in high brightness), and long term resistance against photobleaching. Furthermore, the 
possibility of exciting several NCs emitting at different wavelengths with the same light 
source facilitates multiplexing. However, most of the literature results concern cadmium-
related NCs, in particular CdSe and CdTe QDs, whose applicability is strongly limited 
because of their intrinsic toxicity. InP based NCs, on the other hand, hold the promise of 
being acceptable in both in vitro and in vivo applications, as confirmed by several tests of 
their toxicity [78, 79, 90]. Up till now, only very few reports concern their use in biology, 
as their synthesis is less mastered than in the case of II-VI semiconductor NCs. 
 
The goal of this PhD thesis is to develop the synthesis and aqueous phase transfer 
of NIR-emitting InP/ZnS core/shell NCs and to evaluate their potential as fluorescent 
probes in different biological applications. Therefore, first of all a robust synthesis method 
for producing InP NCs emitting as far as possible in the NIR has to be developed. In a 
second step, the InP NCs will be overcoated with a ZnS shell. The thickness and quality of 
the shell have important consequences on the fluorescence quantum yield (QY) and on the 
photostability of the obtained InP/ZnS core/shell NCs. Chapter II describes this part of the 
thesis. 
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Being hydrophobic after synthesis, the NCs will then be transferred to the aqueous 
phase by means of surface ligand exchange, described in Chapter III. We opt for this 
approach instead of using the encapsulation by amphiphilic molecules with the goal to 
obtain compact NCs (i.e. of low hydrodynamic diameter) with high colloidal stability in 
aqueous medium. Several thiol-containing molecules are being explored, with special 
emphasis on zwitterionic compounds such as cysteine, known for their low non-specific 
binding. An important point to be addressed is the ubiquitously observed reduction of 
fluorescence efficiency upon phase transfer by ligand exchange, This problem risks to be 
even more critical in the case of InP based NCs due to their lower initial QY as compared 
to CdSe or CdTe based NCs. 
 
Finally, the use of the obtained water-solubilized InP/ZnS NCs in biology will be 
explored, (Chapter IV). We will first evaluate their cytotoxicity in cell culture. Due to the 
compact nature of the phase transfer ligands, the ZnS surface of the NCs is still available 
for the grafting of other types of molecules of biological interest. Such direct grafting will 
be used to functionalize the NCs with the cell penetrating peptide maurocalcine. The 
preparation of bimodal fluorescent/MRI probes will be explored by grafting gadolinium 
picolinate complexes on the surface of the QDs. Finally, the use of functional peptides as 
phase transfer agents will be investigated, and the grafting of streptavidin proteins. Owing 
to their high molecular weight and similar size as the NCs, QDs with one, two or more 
proteins per particle can be separated and isolated using gel electrophoresis. 
 
Each chapter contains its corresponding experimental section and references. 
Following the general conclusion, the used characterization methods are summarized in the 
Annex. 
 
 
The research described in this thesis was carried out in close collaboration with 
CEA/Leti/DTBS (Grégory Beaune, Isabelle Texier) and with INSERM U836 (Cathy 
Poillot, Michel De Waard) with financial support from ANR (project PNANO 2007 
“SYNERGIE”) and CEA (program Technologies pour la Santé, project TIMOMA2). 
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2.1 Introduction 
 
Due to greater transparency of living tissues in the near infrared window (650-900) 
[1], NIR emitting InP based nanocrystals have great potential in biological imaging 
applications. Although, accessibility of the NIR emission with InP NCs have been shown 
by various research groups [2, 3], detailed work exclusively focused on synthesis of NIR 
emitting InP NCs is still missing. It has been shown that bigger InP NCs with longer 
emission wavelengths (extending to near infrared region) could be synthesised via multiple 
injections of precursor solutions [2, 4] to the dispersion of smaller InP NCs at high 
temperatures, often followed by a size selective precipitation step [4]. Recently, our group 
has introduced an alternative method for synthesis of InP NCs via phosphine gas [5]. 
Considering the size of the NCs, one of the important aspects of this synthetic scheme is 
that the PH3 is slowly and continuously bubbled into the NCs solution similar to multiple 
injections of precursors. Therefore, the system is well suited for synthesis of larger sized 
NCs. While the influence of different parameters (e.g. reaction temperature, precursor 
concentrations, ratio of the different reactants etc.) on the size evolution of nanocrystals 
was studied with this synthetic approach, the NIR emission from InP and InP/ZnS NCs 
have not been fully explored. This synthetic scheme has been adapted here with special 
goals synthesizing NIR emitting InP NCs for biological application. Section 2.2 of this 
chapter deals with the synthesis and characterisation of the NIR emitting core InP NCs 
while the section 2.3 focuses on the preparation of NIR emitting InP/ZnS core/shell 
nanostructures with high quantum yield in organic medium. Finally, experimental details 
are provided in the last section (cf. 2.4) 
 
2.2 InP nanocrystals 
2.2.1 Synthesis of InP NCs using PH3 gas a phosphorous precursor 
 
Synthesis of NIR emitting InP NCs is based on the reaction of in situ generated PH3 
gas with indium acetate in presence of myristic acid in 1-octadecene reported by our group 
[5].  The two steps of the chemical reactions leading to InP formation are shown in a 
simplified way in equations 2.1a and 2.1b: 
Step I: 3H2SO4 + Zn3P2→2 PH3 + 3Zn 2+ + 3 SO4 2-                                           (2.1a)                                                          
Step II: PH3 + In(CH3COO)3 → InP + 3 CH3CO2H                                           (2.1b)      
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The reaction has been slightly modified from its original reported form. First, the reaction 
was optimized by replacing highly air-sensitive Ca3P2 with Zn3P2 as the phosphorous 
source. Second, zinc stearate is added in the Indium precursor solution. Indeed, the InP NCs 
synthesized without zinc carboxylates have extremely poor photoluminescence efficiency 
and the band edge emission is often not detectable at room temperature. The reaction setup 
for synthesis of NIR emitting InP NCs is shown in Figure 2.1. The phosphine gas was 
generated by addition of 1M sulfuric acid into flask A containing certain amount of Zn3P2 
powder.  The evolved gas is subsequently bubbled into flask B containing a mixture of 
Indium acetate and myristic acid (MA) in 1-octadecene (ODE) with the help of the carrier 
gas Argon. The molar ratio of In:MA is fixed to 1:3 based on earlier studies [5]. The 
temperature inside the flask during the course of the reaction was monitored with a sensor.  
 
 
 
 
 
Figure 2.1 Set up for synthesis of InP NCs based on the reaction of in situ generated PH3 gas with 
indium myristate.  
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PH3 gas is dried on a P2O5 column before injecting to the Indium precursor solution in flask 
B. Another trap containing a saturated aqueous solution of CuSO4 was connected via a 
condenser to flask B in order to neutralize unreacted phosphine gas. Cu2+ ions react with 
PH3 gas to form Cu3P2 evidenced as a black precipitate. Within 2 minutes of phosphine gas 
introduction the solution in flask B changed from transparent to red and became darker 
with growing size of the NCs. The reaction is stopped after 60 minutes as no further change 
of the absorption and emission spectra could be detected for longer heating times. 
 
2.2.2 Study of different reaction parameters 
 
2.2.2.1 P:In molar ratio 
  
Larger sized InP NCs (>4 nm) were obtained using an excess of the phosphine 
precursor (Zn3P2 in flask A). As shown in Figure 2.2a, the first excitonic peak approaches 
700 nm as the P: In molar ratio is increased from 1.6 to 5.8.  The corresponding PL spectra 
with emission maximum at 660, 715 and 747 nm are shown in Figure 2.2.b.  
 
 
 
Figure 2.2 (a) Absorption and (b) emission spectra of InP NCs showing the influence of In: P molar 
ratio on the size of the InP NCs.  The In:MA:Zn molar ratio (1:3:0.4) and the reaction temperature 
are kept constant.  
 
The high amount of Zn3P2 (5.8 molar equivalents) increases the concentration of the 
precursor in the flask above the nucleation threshold and also ensures the continuous supply 
of phosphine precursor for the growth of the InP NCs, similar to the multiple injections of 
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precursor solution.  In a conventional multiple injection method, the additional injections of 
precursor are carried out at certain time intervals to promote further growth.  This 
approach, however, bears the risk of new nucleation events when the concentration of the 
added precursor exceeds nucleation threshold. 
 
2.2.2.2 Addition of zinc stearate 
 
The beneficial effect of zinc carboxylates (e.g. zinc undecylenate [2], zinc stearate 
[6] and zinc acetate [7]) on InP NCs has been reported by several groups. Nann and co-
workers have shown that synthesizing InP nanocrystals in the presence of zinc 
undecylenate and hexadecylamine dramatically increased the PL efficiency (~30%). They 
have hypothesized that zinc carboxylate (in combination with hexadecylamine) improves 
the surface passivation of the InP NCs [2]. A similar observation was reported with zinc 
acetate and the authors have attributed the PL enhancement to surface etching of InP NCs 
by the acetic acid originated in situ from zinc acetate. On the other hand, recent studies by 
Thuy et al. provide a strong evidence of the formation of In(Zn)P alloy structure through 
lattice doping of InP by zinc leading to the PL enhancement [6]. In the experiments carried 
out here with the phosphine gas precursor, the PL efficiency of the InP NCs synthesized 
without zinc stearate was extremely low (< 0.02 %). The addition of zinc stearate during 
the synthesis results in a slight improvement of the room temperature PL NCs (up to a QY 
of ~ 0.5%). Figure 2.3 shows the absorption and emission spectra of the InP NCs 
synthesised with three different concentrations of zinc stearate. The PL maxima of the NCs 
synthesized with lower (In:Zn 1:0.4) and higher (In:Zn 1:1) concentration of zinc stearate 
after 60 minutes of reaction were the same (~747±3 nm). This reveals that there is little 
effect of zinc stearate on the final size of the NCs, which is in contrast to the observations 
using single injection methods [2], where P(TMS)3 is injected to the indium precursor 
solution containing different amounts of zinc carboxylates. The increase in the zinc 
carboxylate concentrations was found to decrease the NCs size, resulting in the blue shift of 
the emission wavelength. However, a careful analysis of the absorption and emission 
spectra of the NCs from the aliquots taken at shorter reaction times reveal that the reaction 
kinetics seems to be faster in case of a lower  amount of the zinc stearate. The PL maxima 
of the two samples synthesized with In:Zn 1:0.4 and 1:1 at different times of the reaction (2 
to 60 minutes) are provided in the table 2.1. Concluding, addition of zinc stearate during 
the synthesis increased the PL of the InP NCs was by a factor of 25. The red shift of the 
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emission peak with time is slower for higher zinc stearate concentration, while the same 
final PL wavelength is attained after 60 minutes. 
 
 
 
Figure 2.3 (a) UV-Vis and (b) the PL spectra (Excitation: 480 nm) of the three InP NCs samples 
synthesized using different concentrations of zinc stearate. Reaction time: 60 minutes.  The In:MA 
molar ratio is 1:3 and the In:P ratio is 1:5.8.  
 
 
In:Zn 
molar 
ratio 
PL emission (nm) 
 
2 min             7 min           15 min            30 min          60 min 
1:04 611 691 735 743 747 
1:1 538 665 723 736 748 
 
Table 2. 1 Effect of zinc stearate on the PL emission of the InP NCs at different reaction time 
 
 
2.2.2.3 Addition of hexadecyl amine (HDA) 
 
The use of hexadecylamine during the InP NCs synthesis in combination with Zinc 
carboxylate is known to increase the PL efficiency of the InP NCs [2]. QY of the InP NCs 
up to 30% have been reported. While these results were reproducible if performed under 
same conditions with the reported precursors, similar attempts with the phosphine gas 
precursor did not improve the PL of the NCs. Figure 2.4 shows the absorption and emission 
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spectra of the InP NCs synthesised with different combinations of HDA and zinc 
carboxylate. No PL was detected when only HDA was used (in absence of zinc stearate). 
Even with combination with zinc stearate the PL QY of the samples were below 1%.  
 
 
 
Figure 2.4 (a) UV and (b) PL spectra of the InP NCs samples synthesized under different 
In:Zn:HDA ratio. Reaction time: 60 minutes. 
 
 
2.2.2.4 Effect of the temperature to modulate the diffusion rate of the monomers and 
the reaction between PH3 and In3+ 
 
Figure 2.5a shows the influence of the reaction temperature on the absorption and 
emission spectra of the NCs. With increase of the reaction temperature a red shift of the 
first excitonic band was observed. This implies that the larger sized NCs were obtained at 
higher temperatures. The two factors that are central to the growth process are diffusion of 
the monomers towards the NCs and the chemical reaction of these monomers with the 
already formed crystals. High temperatures promote both the rate of diffusion and the 
reaction of phosphine gas with the indium precursor as predicted by the Gibbs-Thomson 
and Arrhenius equations respectively. Figure 2.5b shows the corresponding PL spectra. At 
the highest temperature investigated (285oC) the PL intensity was extremely low. 
Moreover, a too high temperature leads to Ostwald ripening characterized by poor size 
distribution and decrease in total concentrations of the nanocrystals.  
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Figure 2.5 (a) Influence of reaction temperature on a) the absorption and (b) PL spectra of the InP 
NCs synthesised with the molar ratio In:MA:P:Zn of 1:3:5.8:0.4 
2.2.2.5 Conclusion 
Based on the influence of the different reaction parameters studied above, it was 
clear that the major factor for the growth of the larger sized NCs was the amount of 
phosphorus precursor.  A certain amount of zinc stearate is important to obtain a detectable 
PL of the InP NCs core. The optimized synthesis of NIR emitting InP NCs involves the use 
of In:P:Zn molar ratio of 1:5.8:0.4 without HDA and at the reaction temperature of 250oC. 
These InP NCs were thoroughly characterized by various physical techniques. The details 
are presented in the following section. 
 
2.2.3 Characterization of the NIR emitting InP NCs 
 
2.2.3.1 Optical characterization 
Figure 2.6a displays the absorption spectrum of the InP NCs after 60 minutes. The 
absorption spectrum shows the hump around 700 nm, which is attributed to the 
characteristic first excitonic transition. However, the peak is rather broad compared to the 
first excitonic peak observed for CdSe NCs or smaller InP NCs [5, 8-10]. Usually 
polydispersity of the NCs is implicated in the broadening of the absorption and emission 
peaks. However, for larger sized NCs, especially InP, the absorption peak becomes 
featureless as the size of the NCs is increased even for the size selected samples of low size 
dispersion [4]. This is attributed to the overlap of electronic transitions with similar 
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intensities, which has been observed experimentally [4]. It arises from the narrowing of the 
spacing of the electronic levels in the conduction and valence band of the NCs with 
increasing size. The full width at half maximum (FWHM) of the PL spectrum of InP NCs 
after 60 minutes is 84 nm. The reported FWHM of the PL spectra of InP-based NCs 
emitting are in the range of 50–100 nm [11]. The growth of the NCs was followed by 
measuring PL spectra of the aliquots taken at different reaction times. The band edge 
emission shifts from 615 nm at 2 minutes to 747 nm at 60 minutes.     
 
 
 
 
Figure 2.6 (a) UV-Vis spectrum of the 747 nm emitting InP NCs. The inset shows a photograph of 
the colloidal solution in hexane. (b) Evolution of the PL spectra of the InP NCs with time (vertically 
shifted for clarity). 
 
2.2.3.2 Structural characterization 
 
The mean size of the 747 nm emitting InP NCs obtained from transmission electron 
microscope is 4.7± 0.85 nm with size dispersion of ~18% (Figure 2.7a). No size selective 
precipitation step was performed prior to size measurements. For the size determination 
(Figure 2.7b) higher resolution images were used to clearly see the border of the NCs 
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obtained.  The values obtained were in agreement with the data reported in the literature 
correlating the size with the excitonic peak [12]. Lattice fringes arising from zinc blende 
(111) InP crystal planes are observable in high resolution TEM images (Figure 2.7 c).  
 
 
 
Figure 2.7 (a) TEM micrograph of 4.70± 0.85 nm InP NCs (b) The size distribution curve c) 
HRTEM image of the same sample of InP NCs. 
 
X-ray diffraction measurements confirm the structure of the InP NCs to be zinc blende. The 
crystallite size calculated with Scherrer’s equation is 3.6 nm, which is lower than the 
particle size (~4.7 nm) obtained from TEM. The Scherrer’s equation estimates the 
crystallite size (D) (< 100 nm) using equation 2.2: 
 
         θ
λ
cosB
KD =                                                                                                                2.2 
 
where K is the shape factor, λ is the wavelength of the X-ray, B is the full width at half 
maximum (FWHM) in radians, and θ is the Bragg angle. For our calculation, we use the 
shape factor of 1.1 which is a theoretical value estimated under the assumption that the 
crystal is a perfect sphere [13].  Even with the accurate shape factor the Scherrer formula 
still provides a lower bound on the crystallite size due to contribution of other factors (e.g. 
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inhomogeneous strain and instrumental effects) to the width of a diffraction peak besides 
crystallite size. In addition, in our case the significant distribution of size and shape of the 
NCs contribute to the discrepancy of the crystallite size obtained from XRD and the 
particle size obtained from TEM.  Figure 2.8 (a) compares the XRD spectra of the 747 nm 
emitting InP NCs with InP NCs synthesized under the same conditions except that no zinc 
stearate was used during the synthesis. Both of the spectra can be perfectly indexed to zinc 
blende InP. There is no evidence of the structural modification on the sample when zinc 
stearate was used during the synthesis. However, this does not rule out the possibility of Zn 
diffusion into InP lattice. It has been previously reported that, even with dopant 
concentration as high as 20%, the peak positions in the XRD spectra of the InP NCs still 
remain unchanged [14]. The Rietveld method was used to fit the measured profile with a 
theoretical line profile. This technique is usually helpful in resolving the overlapping 
reflections and phase identification. 
 
 
 
Figure 2.8 (a) Comparison between the X-ray spectra of pure InP NCs (sample 1) and of the InP 
NCs synthesized in the presence of zinc stearate (sample 2). Red bars indicate the peak positions of 
reference InP (PDF database number: 04-004-1833). (b) Rietveld refinement and indexation of the 
diffraction peaks. 
2.2.3.3 Elemental composition  
The elemental composition of the InP NCs synthesized under various zinc stearate and 
HDA concentrations was determined by energy dispersive X-ray spectroscopy (EDX). The 
mean atomic percentages of P and In in InP NCs synthesized without zinc stearate were 
48.4 and 51.6 respectively. The sample synthesized under zinc stearate contained about 5 % 
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of zinc. It should be noted that the samples have to be purified very carefully prior to these 
measurements (cf. experimental section) in order to remove the adsorbed or free zinc 
stearate from the NCs. The data indicate that zinc replaces indium as we observe a 
concomitant decrease of the In content with increasing Zn content. The lattice doping of 
InP NCs by Zn stearate in situ has already been put into evidence by our group for the 
colloidal InP synthesized  by reaction of indium myristate with P(TMS)3 at elevated 
temperature (250-300°C) in the presence of Zinc stearate [6] i.e. under  similar 
experimental conditions. Both ex situ  [15] and in situ  [16] doping of Zn into InP are 
known in the literature. However, further studies such as for example XPS are required to 
conclude about possible lattice doping in our case. 
 
Figure 2.9 EDX spectra of the samples 1, 2 and 3 (Table 2.2) 
 
 
Sample In:Zn molar ratio Atomic percent 
 
   P %  (SD)        In %  (SD)        Zn % (SD) 
1 1:0 48.4(0.9) 51.6(0.9) - 
2 1:0.4 47.4 (2.4) 47.5(4.4) 5.1(2.6) 
3 1:1 48.7(1.5) 46.1(1.3) 5.2 (1.4) 
 
Table 2.2 The elemental composition of the InP NCs synthesized under various ratio of In and Zn. 
The values are expressed as mean value of atomic percentages obtained with >10 measurements for 
each sample. SD is the standard deviation of the measurements. Other reaction parameters are same 
for all the samples. 
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2.2.4 Conclusion  
 
By using phosphine gas as a precursor InP NCs with band edge emission > 700 nm 
were synthesized. A high P:In molar ratio is crucial for forming larger sized NCs with 
longer emission wavelengths. The reaction temperature also has a direct influence on the 
size and the photoluminescence of the NCs. Within the investigated temperature range 
(210°C to 285°C) the best results in terms of both size of the NCs and photoluminescence 
were obtained at 250°C. The room temperature PL could only be detected when the NCs 
were synthesized in the presence of zinc stearate. The NIR emission wavelengths of the 
NCs synthesized under various conditions are summarized in Table 2.3: 
 
Sample In:Zn:HDA 
molar ratio 
Reaction 
Temperature 
(°C) 
PL 
emission 
(nm) 
1 1:0:0 250 - 
2 1:0.4:0 250 747 
3 1:1:0 250 748 
4 1:1:1 250 725 
5 1:0.4:0.4 250 750 
6 1:0:1 250 - 
7 1:0.4:0 210 722 
8 1:0.4:0 285 - 
 
Table 2.3 Emission wavelength of the InP NCs synthesized under various conditions. For sample 1, 
6 and 8 PL could not be measured. 
 
While an emission wavelength up to 750 nm is reproducibly achieved using the phosphine 
gas route, for application in biological imaging the obtained fluorescence quantum yield 
below 1% is insufficient. One way to improve the fluorescence efficiencies of InP NCs is 
treating with HF. However, in view of biological application, growing a shell of another 
material is desirable. The reason for this is a) an inorganic shell around the core is known to 
dramatically increase the PL quantum efficiency of the core NCs b) imparts both chemical 
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and photo stability to the core material by acting as a protective shell around it. In the 
following section, growth of ZnS shell growth on NIR emitting InP NCs will be addressed. 
 
2.3 NIR emiting InP/ZnS NCs 
 
2.3.1 Introduction 
Zinc sulfide (ZnS) was chosen as the shell material for the following reasons: (a) it 
is a larger band gap material (bulk: 3.6 eV) with type I band alignment (b) the lattice 
mismatch is not too high (InP/ZnS: 7.6 % compared to CdSe/ZnS: 10.6%) c) chemically 
stable and (c) it does not contain toxic elements like Cd, Se etc. Haubold and coworkers 
first reported the growth of ZnS shell on the InP NCs resulting in a PL increase to 15% 
after 3 days and to 23% after 3 weeks [17]. Recent developments in InP/ZnS core/shell 
NCs have led to much shorter reaction time with high PL quantum efficiencies [2, 3].  
 
2.3.2 Calculation of the precursor concentration for ZnS shell growth 
The amount of precursors needed for desired ZnS thickness was estimated using 
the correlation between molar extinction coefficient (ε /L mol-1cm-1), diameter of the NCs 
(D/nm), the bulk crystal parameters such as the density ( ρ /kg m-3) and molar mass 
(m/kgmol-1) and the thickness of one monolayer (d/nm) of ZnS as summarized in the 
literature. The correlation between size of the NCs and the molar extinction coefficient is 
given by the following equation 2.3 [12]: 
 
                            2.3 
 
Once the molar extinction coefficient is calculated, the concentration (C/ mol L-1) of the 
InP NCs could be determined by UV-Vis spectroscopy using Lambert-Beer’s law: 
                                                                                                                          2.4 
 
Where A is the dispersion absorbance (dimensionless) and l is the path length of the used 
cuvette (cm). Assuming that the InP core NCs to be a sphere of radius (r/nm), the volume 
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(Vs /nm-3) of the ZnS shell of thickness d (nm) around the core is given by the difference of 
the volume of the InP/ZnS core/shell and the volume InP core spheres. 
 
33
3
4)(
3
4 rdxrVs ××−×+××= ππ                                                                                       2.5 
 
Where thickness of the ZnS shell is x .d , where x  being the number of ZnS monolayers. 
From this we can calculate the number (Ns) of ZnS monomer units per NC  
 
m
VsNs
2710 −××= ρ                                                                                                               2.6 
 
Finally, the molar quantity of the precursor needed to grow the shell of desired monolayers 
(ns/mmol) can be calculated using equation 2.8 
 
Nsncns ×=                                                                                                                         2.8 
 
Where  nc (mmol) is the molar quantity of the InP NCs core used for the synthesis given 
by VCnc ×= , V being the volume of the colloidal solution (nm3). 
 
2.3.3 Growth of the ZnS shell on the as-prepared InP NCs 
 
A literature method [3] for preparation of InP/ZnS based on injection of zinc and 
sulfur precursor at low temperatures (150-220°C) did not yield any substantial PL increase 
in the case of the obtained NIR emitting InP NCs. Figure 2.10 (a/b) studies the absorption 
and PL spectra of the as synthesized InP NCs (sample 2) upon addition of appropriate 
amount of ZnS (zinc stearate and sulfur in ODE) precursors. The zinc stearate and sulfur 
solution corresponding to 3 monolayer of ZnS shell was slowly injected stepwise (one 
monolayer at a time) at 150°C and heated at 220°C for 30 minutes before the precursor 
solution for the next monolayer was  injected. However, even after third cycle of injection, 
the PL QY of the NCs was still below 1% (Fig. 2.10b). In another experiment, zinc ethyl 
xanthate and zinc stearate were chosen as the precursors for the shell growth [18]. Due to 
low decomposition temperature of zinc ethylxanthate, it is highly effective for ZnS shell 
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synthesis. The ratio of Zn:S in zinc ethyl xanthate is 1:4 and therefore zinc stearate is 
usually added to compensate the shortage of zinc. A calculated amount of ZnS shell 
precursor corresponding to about 5 monolayers of ZnS was slowly injected to the InP NCs 
at 230°C over a period of 1h. However, as in the previous case, no substantial 
improvement of the PL efficiency could be achieved as visible in Fig. 2.10d. 
 
 
 
Figure 2.10 Absorption and PL spectra (a and b) of InP NCs (sample 2) after the injection of ZnS 
precursors (equivalent to 1 to 3 monolayers) performed at 220°C according to a reported protocol 
[3]. Absorption and PL (c and d) spectra of the InP NCs (sample 4) after the slow injection of ZnS 
precursor (equivalent to 5 monolayers) at 230OC during 1h. (PL Excitation: 480 nm)  
 
2.3.4Growth of a ZnS shell on InP NCs treated with zinc stearate  
 
The two step synthesis reported  by our group was adapted to prepare luminescent InP/ZnS 
NCs[5]. In the first step, the as synthesized InP NCs was heated with zinc stearate at 280°C, 
followed by heating with Zn(EX)2 at 210°C. Figure 2.11 shows the absorption and emission 
spectra of the 747 nm emitting InP NCs (sample 2) during the two step ZnS growth 
process. Consistent with the earlier reports [5, 7], heating with zinc stearate in the first step 
already results in dramatic PL increase of the quantum dots (QY~16.5% for sample 2). 
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Interestingly, a blue shift of the peak maximum to 680 nm was observed while the base of 
the peak remained stable. The introduction of the sulfur precursor (equivalent to ~5 
monolayers of ZnS) led to a slight increase in (QY ~18.5%) accompanied by a red shift 
(~50 nm) of the peak maximum yielding a final PL wavelength of 730 nm.  
 
 
 
Figure 2.11 a) UV-Vis and b) PL spectra of the InP NCs during the two step ZnS shell growth 
(excitation: 480 nm). UV-Vis spectra vertically shifted for clarity. 
 
The PL enhancement by addition of zinc stearate was accompanied by a blue shift of peak 
maximum. Under the prevailing conditions (i.e. high temperature, presence of zinc 
stearate), the blue shift can result from various factors, including: (a) alloy formation [6, 
15] (at 280OC) (b) Surface etching and decrease in NCs size [4, 7] or (c) the dielectric 
change of the medium [19, 20]. Similar observations were made by Ryu and co workers on 
heating InP NCs with Zinc acetate [7]. The authors have attributed the blue shift to surface 
etching by acetic acid, which originates from zinc acetate. They have also drawn an 
analogy of the role of acetic acid to the etching of InP nanocrystals by HF [4]. An 
alternative explanation could be the diffusion of ZnS material into InP lattice at 280°C 
similar to the formation of CdSe/ZnS “interfused” nanocrystals at 300°C reported in the 
literature [21]. In our case, we attribute the spectra shift upon heating with zinc stearate to a 
change of the dielectric environment due to the coordination of zinc stearate. A proof for 
this and against size reduction (via etching) comes from the fact that a) after ZnS shell 
growth the initial emission wavelength in reached again b) no broadening of reflections in 
XRD diffractogram of the InP NCs treated with zinc stearate was observed and. Moreover, 
prolonged heating of InP NCs in the presence of ZnS precursor at lower temperature 
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(200°C) did not lead to a significant PL increase. In accordance with Xu and Nann[2], we 
propose that the increase of PL intensity originates from the passivation of surface P atoms 
dangling bonds by zinc stearate. 
 
2.3.5 Characterization of NIR emitting InP/ZnS NCs 
 
2.3.5.1 Optical characterization 
 
Figure 2.12 shows the absorption and emission spectra of the as synthesized and 
size selected fraction of InP/ZnS NCs. The FWHM the as prepared InP/ZnS NCs is 95 nm 
with emission maximum at 730 nm and fluorescence quantum yield of 18%. A low 
intensity shoulder in the red region of the spectrum (~700 nm) was observed (Fig. 2.12b). 
This hump disappears upon size selective precipitation indicating that it may have come 
from size distribution. The size selective precipitation is performed by adding a non-solvent 
(methanol) into the InP NCs dispersed in chloroform (cf. experimental section). Figure 2.14 
compares the InP/ZnS NCs before and after the size selection step. The FWHM the size 
selected InP/ZnS NCs with emission maximum at 742 nm is 72 nm.  
 
 
 
Figure 2.12 Absorption (a) and emission spectra (b) of the NCs before and after the size selective 
precipitation step. 
 
 
 
 
 Chapter II                                                    Synthesis of NIR emitting InP and InP/ZnS NCs. 
 42
2.3.5.2 Structural characterization  
 
In TEM (Fig. 2.13) a small increase of the mean size was observed between the 
core (4.70±0.85 nm) and the core/shell NCs (5.16±0.86 nm). This increase of size 
corresponds to 1-2 monolayer(s) of ZnS shell (thickness of a monolayer: 0.31 nm) [22]. 
Calculation for the InP NCs (5.7 nm) coated with two monolayers of ZnS, results in 
In:P:Zn:S atomic ratio of 1:1:1.3:1.3. The EDX measurements (Fig 2.14b) reveal that 
atomic percentages of In, P, Zn and S are respectively 18.69, 23.79, 28.12 and 29.4 which 
means Zn/In and S/P ratio in the sample are respectively 1.5 and 1.23. Taking into account 
the size and shape distribution of the NCs these results are in fair agreement with the 
expected values from the TEM results. 
 
 
 
Figure 2.13 TEM micrograph of the 4.70±0.85 nm emitting InP core (right) and the 
corresponding 5.16±0.86 nm InP/ZnS core/shell (left) NCs. The scale bar is 10 nm for both 
the images. 
 
The InP/ZnS NCs were further characterized using powder X-ray diffraction. Figure 2.13a 
shows the X-ray diffractogram of purified InP/ZnS NCs compared with the corresponding 
core InP NCs. A clear shift of the peaks for characteristic zinc-blende InP towards those of 
cubic ZnS is observed. The major peaks (e.g. 111 at 33.3°, 220 at 55.8° and 331 at 66.5°) 
arising from ZnS can easily be identified.  
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Figure 2.14 (a) X-ray diffractogram of InP/ZnS core/shell NCs compared with core InP 
NCs (same sample as in Fig 2.11). (b) EDX spectrum of the InP/ZnS NCs. 
 
2.3.6 Conclusion  
 
In the case of NIR emitting InP NCs synthesized using the phosphine precursor the 
adaptation of usual routes for the ZnS shell growth were not successful in terms of increase 
of PL quantum yield. As an alternative, a two step process first by heating the as 
synthesized InP NCs with zinc stearate and then introducing the sulfur precursor was 
developed. NIR emitting InP/ZnS NCs (720-750 nm) with quantum yield up to ~18% at 
room temperature were obtained using this approach. The samples are suitable for the 
aimed biological applications. In the next chapter, their transfer to the aqueous phase will 
be described. 
 
2.4 Experimental section 
 
2.4.1 Chemicals  
 
Except for zinc stearate (90%, Riedel de Haën), zinc phosphide (≥19.4 % active 
phosphor, Riedel de Haën) and zinc ethyl xanthate (>90%, synthesized following reference 
13), all reagents and solvents were purchased from Sigma Aldrich and used as received: 
indium acatate (99.99%), myristic acid (>99%), 1-octadecene (90%), hexadecyl amine 
(98%), stearic acid (>99%), N,N-dimethylformamide (anhydrous, 99.8%) and dioctylamine 
(≥97%). 
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2.4.2  InP NCs synthesis  
 
Sample 2 
0.072 g (0.248 mmol) of Indium acetate, 0.069 g (0.1 mmol) of Zn stearate and 0.17 g (0.75 
mmol) of myristic acid were mixed in 20 g (80 mmol/25 mL) of 1-octadecene (ODE) in a 
50 mL three necked flask (B).  The mixture is heated to ~120°C to obtain a clear solution. 
The flask is then degassed for 1 h under vacuum (~3. 10-2 mbar). During this step the 
solution is stirred magnetically at 600 rpm. Simultaneously, in another flask (A) as shown 
in the Figure 2.1, 0.45 g (1.74 mmol) of fine powdered Zn3P2 is weighed and degassed. 
Both the flasks are backfilled with Argon. The temperature of flask B is increased to 
250°C.  10 mL of 1M H2SO4 solution is injected to the flask A to generate phosphine gas 
and the gas is carried to the flask B by a strong flow of Argon. Within 2 minutes, the 
solution turns reddish black. Under constant Ar flux, the reaction was continued for 1h.  
PL: 747 nm, QY: 0.3 %  
 
Sample 1 
Synthesized as above (sample 2), except no zinc stearate is used. 
PL: no emission was detectable. 
 
Sample 3  
Synthesized as above (sample 2), except 0.158 g (0.2 mmol) of zinc stearate was used 
instead of 0.069 g (0.1 mmol). 
PL emission: 748 nm, QY: 0.04 % 
 
Sample 4 
0.0720 g (0.248 mmol) of indium acetate, 0.1074 g (0.25 mmol) of zinc undecynelate, 
0.120 g (0.5 mmol) of hexadecylamine  and 0.0712 g (0.75 mmol) of stearic acid are mixed 
in 20 g (80 mmol) of 1-Octadecene (ODE) in a 50 mL three necked flask (B).  The rest of 
the reaction is the same as for sample 2. 
PL: 725 nm, QY: 0.2 %  
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Sample 5  
Synthesized as above (sample 2), except 0.158 g (0.2 mmol) of zinc stearate is used instead 
of 0.069 g (0.1 mmol). 
PL: 753 nm, QY: 0.06 %  
 
Sample 6  
Synthesized as sample 2, except that 0.072 g (0.2 mmol) of hexadecylamine is used instead 
of 0.069 g (0.1 mmol) zinc stearate. 
PL: no emission detectable 
 
Sample 7 
Synthesized as above (sample 2), except that the reaction was performed at 210°C for 1h. 
PL: 722 nm, QY: 0.1%  
 
Sample 8 
Synthesized as sample 2, except that the reaction is performed at 285°C for 1h. 
PL: no emission detectable 
 
2.4.3 InP/ZnS NCs synthesis 
 
2.4.3.1 Growth of ZnS shell on the as-prepared InP NCs 
 
Method 1 
10 mL of 0.1 M zinc stearate and 0.1 M sulfur solution (precursor solution) was prepared in 
degassed ODE. 5 mL (~0.3 µmol) of the as-synthesized 747 nm emitting InP NCs (sample 
2) are degassed for 30 minutes under vacuum (~3. 10-2 mbar) in a 50 mL three-neck flask 
connected to the Schlenk line. 0.7 ml of   the precursor solution was injected at 150°C and 
then heated at 220°C with constant stirring at 600 rpm for 30 minutes. This is followed by a 
second (1 mL) and third injection (1.2 mL) after 30 minutes of interval. 
PL: 737 nm, QY: 0.18%  
Method 2 
11 mL (~0.3 µmol) of the as-synthesized 725 nm emitting InP NCs (sample 4) were 
degassed for 30 minutes under vacuum (~3. 10-2 mbar) in a 50 mL three neck flask 
connected to the Schlenk line. 0.79 g (1.25 mmol) of zinc stearate and 0.095 g (0.31 mmol) 
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of zinc ethylxanthate are dissolved in 6 mL dioctylamine and injected into the flask 
containing InP NCs at 230°C. Rate of injection: 6 mL/hr 
PL: 731 nm, QY: 0.1%  
 
2.4.3.2 Growth of ZnS shell on the InP NCs treated with zinc stearate  
11 mL (~0.3 µmol) of the as-synthesized InP NCs (sample 2) were mixed with 0.79 g (1.25 
mmol) of zinc stearate (in 3 mL ODE) and the mixture is degassed for 30 minutes under 
vacuum (~3. 10-2 mbar).  The mixture is then heated to 280°C with constant stirring at 600 
rpm for 4hrs. 0.095 g (0.31 mmol) of zinc ethylxanthate (in a mixture of 0.2 mL 
dimethylformamide (DMF), 1 mL of ODE and 1 mL of toluene) is slowly injected into the 
solution slowly (rate of injection: 4.4 mL/h) at 210°C.  
PL: 730 nm, QY: 18%, FWHM: 96 nm 
 
2.4.4 Work up 
 
Method 1 (Fig. 2.15) 
10 mL of as synthesized InP/ZnS NCs in ODE are precipitated by adding an excess of 
acetone (30 mL). The precipitate is filtered through a filtration column with a glass filter 
63. The solution is heated during the filtration (40-50°C) to dissolve the excess of zinc 
stearate in acetone. 
 
 
Figure 2.15: Diagram of filtration set-up using suction. 
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Method 2 (Fig. 2.16) 
 
5 mL of InP/ZnS NCs are mixed with 15 mL of anhydrous acetone and the mixture is 
centrifuged at 1000 rpm for 5 minutes. The precipitate is dispersed in 5mL of anhydrous 
hexane and centrifuged at 2800 g for 1 minute. The excess of zinc stearate, which is 
insoluble in hexane precipitates, while InP/ZnS NCs remain in the solvent as a stable sol. A 
fraction of bigger NCs may settle down along with zinc stearate in this step. Therefore, the 
last step is repeated 2-3 times until the precipitate is free of NCs (indicated by the white 
color of zinc stearate).  
 
Figure 2.16: Scheme depicting the purification by centrifugation. 
 
2.4.5 Size selective precipitation 
 
Around 3 mg of purified 730 nm emitting InP/ZnS QDs are dissolved in 2 mL of 
chloroform, subsequently anhydrous methanol is added dropwise under stirring until the 
solution becomes slightly turbid. The fraction of precipitated QDs is collected by 
centrifugation (4 min, 1792 g). This procedure is repeated 3 times to collect fraction 
containing the larger sized NCs. 
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3.1 Introduction 
 
In view of their application in biological imaging, the basic requirements for 
quantum dots are: a) water solubility b) colloidal stability in physiological pH over an 
extended period of time c) good fluorescence efficiency d) small hydrodynamic diameter 
and d) and low non-specific binding in biological environment. The transfer of 
semiconductor NCs prepared in organic solvents have no intrinsic aqueous solubility and 
therefore their phase transfer to aqueous medium is an essential step for benefiting from the 
progress of nanoscience in biotechnology [1-3].  One way to address the issue of colloidal 
stability is the use of specially designed organic ligands — a strategy that has been 
extensively applied to gold and silver nanoparticles (NPs). Mono- as well as dithioalkylated 
polyethylene glycols [4, 5], peptide based ligands [6, 7, 50, 51], phospholipid micelles [8] 
and amphiphilic polymers[9] have been used with the goal to prevent from particle 
aggregation after phase transfer. Despite remarkable stability in aqueous environment of 
various NCs and NPs capped with these engineered ligands, the small amino acid cysteine 
has recently also drawn strong attention, mainly due to its zwitterionic nature, compact size 
and commercial availability [10, 11]. Both cationic and anionic ligands exhibit non-specific 
interactions with serum proteins, resulting in an increased hydrodynamic diameter (Dh). In 
contrast, NCs coated with these small ligands (e.g. cysteine) have been shown to produce 
small hydrodynamic diameters (~5-10nm) [10, 11]. For in vitro and in vivo studies, the 
compact size of the fluorescent probe can be mandatory. Examples are monitoring the 
traffic within synapses [12], extravagation of QDs from vasculature[13] and renal clearance 
observed in mice [11]. In the latter case, very compact (Dh~6nm) cysteine-capped 
CdSe/CdZnS NCs have been applied [11]. However, these NCs obtained by phase transfer 
with cysteine at physiological pH (7.4), were found to be stable only 24 hours at 4°C before 
their precipitation. The colloidal stability could be increased to one week by adding sodium 
borohydroxide and dithiothreitol (DTT), reducing agents that prevent ligand desorption 
under disulfide formation [11].  
 
In addition to colloidal stability, phase transferring fluorescent semiconductor NCs 
into water should also maintain the fluorescence quantum yield (QY) during the transfer 
reaction.  The decrease of QY is commonly reported from both core semiconductor NCs as 
well as core/shell NCs such as CdSe/ZnS [5, 14], CdSe/ZnCdS [11] and InP/ZnS [15], 
implying that despite the inorganic shell, the fluorescence properties of the core could still 
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be influenced by the surrounding environment in solution (e.g. nature of organic capping 
ligands, pH etc.). Quenching in presence of a protective inorganic shell can be attributed to 
defects in the shell or to its insufficient thickness [14]. The loss of fluorescence becomes a 
major issue when dealing with new classes of cadmium-free semiconductor NCs that are 
not as fluorescent as Cd based NCs, whose QY has been reported to reach almost 100% in 
organic medium [16-18]. InP/ZnS core/shell nanocrystals, for example, have attracted 
much attention as alternative to Cd chalcogenide QDs. In this chapter we investigate the 
phase transfer of InP/ZnS QDs using commercially available small thiolated ligands. In 
particular the emphasis will be given on colloidal stability, conservation of fluorescence 
and anti-fouling surface to reduce nonspecific interaction with cells. For all phase transfer 
agents studied, the deprotonation of the thiol function by appropriately adjusting the pH of 
the aqueous phase is of prime importance to obtain strong ligand binding to the NCs’ 
surface. The versatility of the approach is demonstrated by successfully phase transferring 
CdSe nanospheres and nanorods as well as CdSe/CdS nanorods, CuInSe2, CuInS2/ZnS 
core/shell and CdSe/CdS/ZnS nanocrystals in addition to InP and InP/ZnS NCs. Finally, we 
elucidate the origin of fluorescence quenching of cysteine-capped QDs, which is related to 
cysteine dimer (cystine) formation. We further show that penicillamine, a molecule less 
prone to dimerization than cysteine, constitutes a more suitable transfer agent in view of 
biological applications.  
 
3.2 Phase transfer 
 
The transfer of NCs synthesized in organic medium to aqueous medium involves 
exchanging a hydrophobic surface ligand with a hydrophilic molecule containing an 
appropriate anchor functional group. The ligand exchange of InP/ZnS NCs is achieved by 
vigorously stirring a biphasic mixture of QDs in chloroform and of the thiol containing 
ligand in basic aqueous solution (Figure 3.1). Thiol containing molecules are widely used 
for capping the NCs surface. The driving force of the reaction is the high binding energy of 
the thiols with ZnS surface as compared to carboxylic acids. Strong bonds between ligand 
and the NCs surface also provide colloidal stability to the NCs in aqueous medium. The 
calculated binding energy for thiolated ions to cations at the NCs’ surface is much higher 
than the binding energy of the protonated thiol group. For example, in the case of CdSe, the 
calculated binding energies in vacuum for the thiolate and the thiol group are 1283 and 34.7 
kJ/mol, respectively [19]. Similarly, in case of the shell material zinc sulfide, a relatively  
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Figure 3.1: Phase transfer of InP/ZnS NCs in presence of a hydrophilic thiolated ligand at a pH 
conducive for the deprotonation of the thiol group. The photographs show the NCs in chloroform 
and water respectively before and after the phase transfer under UV light. 
 
high binding energy has been reported for Zn-Sthiolate (194.7 kJ/mol) while Zn-Sthiol account 
only for 31,8 kJ/mol, respectively [20]. Since thiolate formation is pH dependent, the 
control of the pH during the phase transfer is of primary importance. The reaction pH 
should be chosen high enough (typically 8-11) for the deprotonation of the thiol group. On 
the other hand basic pH values favour undesired disulfide formation. To determine the 
optimal pH for the phase transfer reaction, acid-base titration curves were acquired by 
titrating a 0.2 M solution of various ligands with 0.5 M tetramethylammonium hydroxide, 
TMAH. The titration curves for the following thiol group containing ligands were 
measured (Scheme 3.1 and Fig. 3.2): cysteine (Cys), dihydrolipoic acid (DHLA), 
penicillamine (Pen), thioglycolic acid (TGA), 3-mercaptopropanoic acid (MPA), 11-
mercaptoundecanoic acid (MUA). These ligands behave as polyprotic acids due to the 
presence of multiple acid functionalities. The strongly acidic carboxylic group (-COOH) 
already dissociates at acidic to neutral pH, where as a sufficiently high pH (8-11) is 
required to dissociate the –SH group. This simple acid-base titration gives us a direct 
correlation between thiol dissociation and the pH of the solution. As seen in the titration 
curves (Fig. 3.2), the successive addition of the strong base TMAH leads to steady increase 
in the pH of the solution. However, in the pH range where the carboxylic acid group (<pH 
4) or the thiol group (>pH 8) of the ligand starts dissociating, the rate of pH increase as a 
function of base addition is slowed down. As for example, thiol dissociation of TGA starts 
at ~8.7 resulting in the slowing of pH increase due to the release of protons which 
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neutralize the added base until ~10.5 when the dissociation is complete and the further 
addition of TMAH effectively increases the pH. By analyzing the titration curves we 
determined the pH used for the phase transfer reactions (Table 3.1). The NCs phase 
transferred with MUA, MPA and DHLA capped NCs were very stable in basic pH (~8-11) 
i.e. no increase of the hydrodynamic diameter observed for at least 10 weeks while the 
stability decreased to just a few hours when stored in neutral to acidic pH. On the other 
hand cysteine, penicillamine and thioglycolic capped NCs were stable in wider range of 
pHs (~6-10). The NCs transferred with these ligands have negative zeta potential in PBS 
buffer (pH 7.4).  
 
 
Scheme 3.1: Structures and abbreviations of the used ligands for aqueous phase transfer. 
 
 
 
Figure 3.2: Titration curves of (a) 3-mercaptopropanoic acid (MPA) and thioglycolic acid acid 
(TGA); (b) 11-mercaptoundecanoic acid (MUA) and dihydrolipoic acid (DHLA); (c) L-cysteine 
(Cys) and D-penicillamine (Pen). A 0.5 M aqueous solution of tetramethylammonium hydroxide 
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(TMAH) is used as the base during the titration. N.B.: MUA and DHLA are not soluble in acidic or 
neutral pH range. 
An unusually low zeta potential was observed for thioglycolic acid in 1 X PBS. This could 
be due to the complete degradation of surface thioglycolic acid in basic pH [21]. The 
breaking of intra ligand –C-S bond of thioglycolic acid on CdTe NCs has been shown 
experimentally [22]. We also note that cysteine yields significantly lower zeta potential (-
22.3 mV) than other ligands whose values are in the range of -32 to -41 mV. The typical 
ligand: QD ratio during the transfer reaction was ~104 to 105.  Lower ligand: QD ratios (103 
or 102) produced a marked increase of the mean Dh. For example, with 660 nm emitting 
InP/ZnS NCs, mean hydrodynamic diameter (Dh) values obtained from dynamic light 
scattering (DLS) measurements were 7.9, 7.5, 9.6, and 10.7 nm respectively, for the 
ligand:QD ratios of 105, 104, 103 and 102 (Table 3.2). Also, the QDs transferred with lower 
ligand concentration (samples 1 and 2) aggregated during the purification process, 
indicating incomplete ligand exchange. The simple law of mass action could explain the 
inefficiencies of the phase transfer process at low ligand concentration. Using a ligand: QD 
ratio ≥104 during the phase transfer reaction, the QDs moved quantitatively from the 
organic to the aqueous phase within two hours, as could be judged from the colour change 
of both phases. To assess the efficiency of the transfer process, the transfer yield was 
calculated for the QDs after purification. In fact, the fraction of QDs having an insufficient 
 
 
Ligand
Thiol  
pKa 
Reaction pH
 
Transfer Yield 
(%) 
Zeta potential 
(mV) 
DHLA 10.7  11.9 89  -32.4±4.3 
Cys 8.35 9.3 60 -22.3 ±0.7 
Pen 7.9 9 58 -32.7 ±2.3 
TGA 9.78 10.3 74 -10.7 ±1.0 
MPA 10.8 11 78 -40.9 ±1.7 
MUA ~11 11.6 98 -36.5 ±0.7 
 
Table 3.1:  Thiol pKa values for each ligand, reaction pH used for the phase transfer, transfer yield 
(amount of QDs in water/amount of QDs in chloroform) and zeta potential measured in in 1X PBS 
buffer for the phase transferred QDs. 
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surface coverage with the new hydrophilic ligands could not be redispersed in water of 
buffer solution. Therefore the transfer yield is always below 100% and depends on the 
nature of the transfer ligand. More generally it also depends on the bond strength of the 
original ligands on the NCs’ surface which in our case is the same for all the samples. To 
calculate the transfer yield, the concentration of the sample before and after phase transfer 
is estimated from the first excitonic peak in the UV-Vis spectra using the empirical 
correlations between the excitonic peak, size and molar extinction coefficient[23]. The 
obtained values varied from 58% to 98% for the different ligands (Table 3.1).   
 
Sample No. [Ligand]/[QD] Hydrodynamic diameter (nm) 
1 100 10.7±1.7 
2 1000 9.6±0.8 
3 10000 7.5±2.6 
4 100000 7.9±1.3 
 
Table 3.2: Hydrodynamic diameter of the NCs transferred using different ligand (penicillamine): 
QD ratios (TEM diameter ~4 nm). 
 
3.3 Photoluminescence of the phase transferred InP/ZnS NCs 
 
Consistent with earlier reports [1, 5, 11, 24, 25], the phase transfer by means of 
surface ligand exchange is generally accompanied by a significant decrease of the 
fluorescence intensity. In Fig. 3.3a the integrated photoluminescence is plotted against 
absorbance, which gives a direct comparison of the QY by comparing the slopes of the 
different curves.  
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Figure 3.3: (a) Integrated photoluminescence vs. absorbance plot for NCs capped with the different 
ligands in water (TGA, MPA, Pen, MUA, DHLA, Cys) and in hexanes (MA). Absorbance is 
measured at 480 nm. Straight lines are added to guide the eye. (b) Photograph showing the obtained 
colloidal solutions under UV light (365 nm). (c) Normalized PL spectra of these samples (λex = 480 
nm). 
 
In our studies an unusually pronounced quenching was seen in the case of cysteine and 
DHLA, retaining only around 4% and 10%, respectively. The possible source of this 
quenching and prevention will be discussed in section 3.4. Penicillamine (retained PL 
~30%), TGA (~42 %), MPA (~34%), and MUA (~26%) capped NCs were comparably 
brighter as can be directly seen when the samples are put under a UV lamp (Fig. 3.3b). Fig. 
3.3c shows the normalized PL of the QDs with different ligands in water. A slight red shift 
was observed (9 nm for MUA, 6 nm for DHLA, 15 nm for cysteine, 3 nm for MPA and 1 
nm for TGA), which is attributed to the change of the dielectric environment of the NCs’ 
surface charge [26] and eventually on solvatochromic effects.  
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3.4 Zwitterionic ligands  
 
Reducing non-specific binding of NCs in biological medium is a major challenge 
when bio-applications of quantum dots are aimed. Adsorption of serum proteins leads to 
increase in hydrodynamic diameter of the NCs, complicating the transport and clearance 
processes. Initially, surfaces coated with self assembled monolayers (SAMs) of 
polyethylene ethylene glycols  have been shown to strongly reduces the adsorption of 
proteins [27]. Holmlin et al. first showed that the zwitterionic SAMs were equally efficient 
against nonspecific adsorption of proteins [28]. This concept has been recently extended to 
quantum dots with enormous success [10, 11, 28]. It has been shown that NCs capped 
zwitterionic ligands provide an antibiofouling surface [28], making quantum dots averse to 
non-specific adhesion with cells and serum proteins. Successful renal clearances of the 
zwitterionic cysteine capped quantum dots have been reported [11]. In addition, the 
zwitterionic ligand coated NCs have better colloidal stability in neutral to basic pH range 
due to the presence of positively and negatively charged groups [29]. For these reasons we 
focused our study in the following two zwitterionic ligands: L-cysteine and D-
penicillamine. Both of them are commercially available and share the following features: a) 
non-toxic b) small size and c) zwitterionic. 
 
 
3.4.1 Cysteine coated InP/ZnS NCs 
 
Fig.3.4 shows the hydrodynamic diameter of the cysteine capped NCs in 1X PBS 
buffer at ~pH 7.4 plotted as a function of time. Within the experimental error, during three 
months no size increase was observed.  It is interesting to note that no additional reducing 
agents such as dithiothereitol (DTT) are added to protect from cysteine oxidation, which 
has been attributed to trigger NCs’ aggregation in earlier reports [11]. The samples have 
been thoroughly purified by centrifugation method (cf. experimental section) to ensure 
removal of free ligands. 
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Figure 3.4: Stability of cysteine capped InP/ZnS NCs in 1X PBS buffer illustrated by the evolution 
of their hydrodynamic diameter as a function of time (TEM diameter 5.1±0.7 nm). Right: 
photograph of the colloidal solution after three months. The hydrodynamic diameters are measured 
in number distribution. 
 
However, the dramatic PL quenching of cysteine capped InP/ZnS NCs is a major drawback 
as far as their bio-applications are concerned. We consistently observed the discussed 
behaviour for different sized InP/ZnS NCs. As seen in Figure 3.3a, a similar quenching 
effect was observed with dihydrolipoic acid (DHLA) another transfer ligand [3]. Therefore, 
it is necessary to identify and eliminate the source of PL quenching at the NC’s surface. 
Seen alone, these results imply that the thickness (~1 nm) and/or quality of the ZnS shell 
are not sufficient. Both Cys and DHLA are susceptible to oxidation under disulphide 
formation in a solution of basic pH: in the case of DHLA an intermolecular reaction 
yielding thioactic acid takes place; in the case of cysteine, its dimer (cystine) is formed. 
Disulfides, especially cystine, are well known to quench the fluorescence of organic 
molecules such as tryptophan[30] and tyrosine[31]. Moreover, cysteine efficiently 
quenches the fluorescence of MPA-capped CdTe QDs at pH > 9.6[32]. The observed 
quenching has been attributed to hole transfer from the band edge (HOMO) of the QDs to 
the cysteine/cystine redox energy level. To understand the quenching mechanism in our 
case, we performed the phase transfer of InP/ZnS NCs with cysteine in presence and 
absence of tris(2-carboxyethyl) phosphine hydrochloride (TCEP) [33] — a molecule which 
is used for the selective reduction of disulfide bonds within a wide pH range. Remarkably, 
in presence of TCEP, 72% of the initial PL QY was retained (Fig. 3.5a/b) with 730 nm 
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emitting InP/ZnS NCs. The beneficial effect of TCEP on the QY was also observed when 
the quenched quantum dots (QY<0.5%) were subsequently treated with TCEP. Within 2 
hours, the fluorescence already increased 5 fold and the maximum increase was 13 fold 
when the solution was kept in dark at room temperature for 72 hours (Fig. 3.5c). In other 
words, a substantial fraction of the PL intensity lost during the phase transfer using cysteine 
at pH ~9, could be recovered by means of the addition of the disulfide reducing agent 
TCEP. Similarly, the fluorescence efficiency of the “quenched” DHLA capped NCs could 
be recovered. In all experiments, 
 
 
Figure 3.5: a) Phase transfer of InP/ZnS NCs (A) at pH~9 with cysteine in presence (B) and in 
absence (C) of TCEP; (D) fluorescence recovery by addition of 0.5 equivalents of TCEP (with 
respect to cysteine). b) Integrated PL intensities as a function of absorbance for the samples A, B and 
C. c) Evolution of the relative PL intensity with time after TCEP addition (sample D). 
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Scheme 3.2: Possible mechanisms taking place in the fluorescence quenching induced by hole (h+) 
transfer from the QD to cystine and the PL recovery in presence of tris(2-carboxyethyl)phosphine 
(TCEP). In addition of being a reducing agent for cystine, TCEP and its oxidized form TCEPO can 
also act as nanocrystals’ surface ligands. 
 
the pH was kept constant (~9) in order to rule out any pH related changes in the PL 
emission. The amount of TCEP with respect to cysteine-capped QDs was chosen in a way 
that even if there was 100% disulfide bond formation, still sufficient TCEP would be 
present to reduce them. The hypothetical mechanisms occurring during PL quenching and 
recovery are illustrated in Scheme 3.2: (1) hole transfer from the valence band of InP/ZnS 
NCs to cystine bound or in proximity to the surface, leading to fluorescence quenching; (2) 
cystine reduction by TCEP, while TCEP itself gets oxidised to TCEPO [33]. Both TCEP 
and TCEPO have functionalities (phosphine and phosphine oxide) that are known to 
passivate the surface of various types of semiconductor NCs, including InP[34] and to 
improve their photoluminescence efficiency.  Depending on the nature of QDs, different 
ligands show different quenching properties. For example, thiols such as amino ethanethiol 
or hexanethiol give high quantum yields with CdTe NCs while they quench almost 
completely the fluorescence of CdSe NCs[35]. This behaviour was attributed to the 
difference in the energetic position of the valence band of CdTe and CdSe with respect to 
the thiol redox level – in the case of CdSe, the lower lying valence band edge leads to hole 
trapping on the thiols. In the other example cited earlier, at pH > 9.6 the addition of 
cysteine to MPA-capped CdTe NCs led to a pronounced drop in fluorescence [32]. In 
contrast, no such quenching was observed with homocysteine, a homologue of cysteine 
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with an additional methylene group. The observed behaviour has been explained by the 
different energetic position of the HOMO levels of both molecules, lying higher (cysteine) 
or lower (homocysteine) than the valence band of CdTe [32]. To date, no biological studies 
with cysteine-capped InP/ZnS NCs have been reported despite the cited advantages of 
cysteine as a capping ligand of CdSe-based QDs [11]. One of the reasons could be the 
strong PL quenching of InP/ZnS NCs by cystine, which we have put into evidence here. 
Although the phase transfer reaction carried out at ~pH 9 with cysteine leads to stable NCs 
in water, it also favours cystine generation. We propose a twofold solution to this problem: 
a) the use of TCEP during the transfer with cysteine; b) the use of penicillamine, providing 
similar properties as cysteine as being bio-compatible, compact and zwitterionic but being 
less prone to dimerization.  
 
 
 
Figure 3.6:  Evolution of DHLA-capped ~640 nm emitting InP/ZnS NCs (200 µL, ~5 µM, pH~9) 
upon addition of 40 µL of a 0.5 M aqueous solution of TCEP (tris(2-carboxyethyl) phosphine) (a) 
Photoluminescence spectra recorded at different times after TCEP addition (excitation wavelength 
480 nm); (b) evolution of the integrated emission intensity with time 
 
We observed the formation of small white crystals on the bottom of the vial when the as 
transferred NCs were kept for 24 hours without purification and removal of excess cysteine 
(Fig. 3.7). Interestingly, the NCs themselves had not precipitated. As expected for cystine, 
the crystals were insoluble in water, alcohol, chloroform and acetone and could only be 
solubilized in water at higher pH (> 12). 1H NMR analysis unambiguously confirms the 
cystine formation (Figure 3.7). Cystine is responsible for up to 4% of all kidney stones due 
to its insolubility at the pH prevalent in the kidneys. Therefore, in vivo studies using 
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InP/ZnS QDs capped with cysteine could possibly result in side effects related to insoluble 
cystine. Penicillamine, on the other hand, is used in the treatment of cystinurea, a genetic 
disease caused by accumulation of cystine in the kidneys [36]. In fact, penicillamine-
cysteine disulfide has a much higher solubility at near-neutral pH values than cystine.  
 
 
 
 
Figure 3.7: a) Cystine formation during 24 hrs storage of cysteine-capped InP/ZnS NCs. b) 1H-
NMR spectra of commercial L-cysteine, of cystine formed when keeping a solution of L-cysteine at 
pH~9 for 24 hrs at room temperature and of cystine recovered from NCs solution after 24hrs. Due to 
the insolubility of cystine in water at neutral pH, the spectra have been recorded in a D2O/NaOH 
mixture at pH 11. The chemical shifts of the methine and methylene protons in L-cysteine account 
for 3.9 and 2.95 ppm, respectively. In cystine, the signal of the methine protons is shifted to 3.45 
ppm and the methylene protons split into two multiplets at 3.0 and 2.78 ppm, respectively, owing to 
the molecular chirality. 
 
3.4.2 Penicillamine coated InP/ZnS NCs 
 
In contrast to cysteine, penicillamine contains two methyl groups (instead of 
protons) at the carbon atom in α position to the thiol group. This structural difference has a 
strong influence on the reactivity of both molecules. In particular, the sterically hindered 
thiol group in penicillamine makes it less susceptible to oxidation as compared to cysteine. 
In literature, penicillamine has been used as a capping ligand in the aqueous synthesis of 
QDs [37] and also as a phase transfer agent at pH 7.4 (PBS buffer) [29].  While the stability 
of the CdSe/ZnS NCs phase transferred with penicillamine at pH 7.4 was high, a rather 
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long reaction time (18h) has been reported [29]. On the other hand, by adjusting the pH to 9 
we have seen that the phase transfer reaction takes place within 2h or less and after 
purification and transfer to 1X PBS buffer the product is stable for approximately ten 
weeks (Fig. 3.8a) before an increase of the hydrodynamic diameter is observed. The typical 
hydrodynamic diameter obtained for 610 nm (orange), 660 nm (red) and 730 nm (near 
infrared) emitting InP/ZnS NCs in water were respectively 6.9±1.3, 7.9±1 and 8±0.5 nm 
(Fig. 3.8b).  
 
 
 
Figure 3.8: a) Hydrodynamic diameter of penicillamine-capped InP/ZnS NCs (emission: 730 nm) in 
1X PBS buffer as a function of time. b) Hydrodynamic diameter measurements of 610 nm, 660 nm 
and 730 nm emitting NCs in water directly after the phase transfer. Multiple runs (> 3) were 
performed for each sample. C) Integrated photoluminescence vs. absorbance plot for the 730-nm 
emitting NCs in the presence (green) and absence (blue) of TCEP during the phase transfer. 
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In comparison to cysteine (retained QY 4%), with penicillamine as the phase transfer 
ligand the retained QY of the same InP/ZnS NCs is around 30-40%. The retained PL 
quantum yield of the aqueous InP/ZnS NCs could further be improved to ~65% by adding 
TCEP during the transfer (Fig 3.9c). The maximum retained integrated PL intensities are 
45% (emission at 610 nm), 63% (660 nm) and 65 % (730 nm) for the Pen-capped InP/ZnS 
QDs. In addition to the florescence properties, chirality in QDs induced by optically active 
ligands such as D-penicillamine (or L-penicillamine) recently has attracted interest. Besides 
chiral gold [38] and silver nanoparticles [39], the first chiral QDs were reported by 
Moloney et. al. through microwave heating of Cd and Se precursors in the presence of the 
optically active enantiomers of penicillamine in water [37]. This concept has more recently 
been enlarged to the aqueous synthesis of chiral CdS nano-tetrapods [40]. The chiral NCs 
have a high potential for the development of chiral nanosensors and chirooptical devices 
[41].The purified D-pencillamine capped NCs showed circular dichroism in 1X PBS buffer 
with a maximum and minimum at 244 nm and 266 nm, respectively, in addition to a peak at 
228 nm. The latter one is close to 234 nm, the characteristic peak of D-penicillamine (Fig. 
39a/b). Three different models have been proposed to account for circular diochroism 
(chirality) in NCs: first, inherently chiral cores; second, inherently achiral cores with thiol 
head groups adsorbed on the surface in a chiral pattern and third, with only chiral 
adsorbates [42, 43]. In our case we do not know which model applies at the present stage. 
Obtaining chiral QDs without having to use chiral stabilizing ligands during synthesis has 
advantages in terms of the ability to choose the NCs’ nature, size, and shape.  
 
 
 
Figure 3.9: Circular dichroism (CD) spectra of (a) D-penicillamine, b) D-pencillamine- capped 
InP/ZnS QDs in 1X PBS buffer. The QDs are passed through a Nap5 size selective column prior to 
the measurement.  
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3.5 Versatility of the phase transfer protocol 
 
In addition to different sized InP/ZnS NCs, the protocol could be successfully 
applied to InP core NCs, CdSe and CdSe/CdS nanorods, triangular shaped CuInSe2 NCs, 
and spherical CdSe/CdS/ZnS as well as CuInS2/ZnS core/shell structures without any 
modification of the procedure (Fig 3.10). The transfer yield was strongly dependent on the 
initial surface ligands. In the case of NCs already capped with thiols (e.g. CuInS2/ZnS) it 
was much lower (<30%) than in the case of fatty acid (myristic acid or stearic acid) or 
amine (hexadecylamine or oleylamine) capped QDs (50-98%).  
 
 
 
 
Figure 3.10: Photograph of (a) 6 nm CdSe/CdS/ZnS cores/shell/shell NCs transferred with 
penicillamine; (b) 7 nm CuInS2 NCs transferred with MUA; (c) 3.5 x 15 nm CdSe nanorods 
transferred with cysteine; (d) 4 x 32 nm CdSe/CdS nanorods transferred with penicillamine and (e) 
CuInSe2 (edge length 18 nm) triangles transferred with penicillamine. “1” indicates the samples in 
chloroform and “2” the corresponding samples in water. 
 
Fig. 3.11 shows the UV-Vis and PL spectra of some samples before and after the phase 
transfer using different ligands. While in the case of the CdSe based systems the transfer is 
accompanied by a decrease of the PL intensity without spectral shift, in the case of 
CIS/ZnS NCs a red shift of ~50 nm was observed. This shift is attributed to the higher 
sensitivity of the photoluminescence properties of CIS/ZnS to surface modification than the 
CdSe based NCs. In fact, the emission of the CIS/ZnS NCs is not excitonic recombination 
but to donor-acceptor pair recombination implying surface related defect states [44]. 
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Figure 3.10: UV-Vis and PL spectra of a) ~6 nm CdSe/CdS/ZnS cores/shell/shell NCs capped with 
penicillamine; b) ~7 nm CuInS2/ZnS core/shell NCs capped with MUA; c) ~3.5x15 nm CdSe 
nanorods capped with cysteine and d) ~4x32 nm CdSe/CdS nanorods with penicillamine. Red lines: 
spectra recorded in water, black lines: spectra in organic phase (hexane or chloroform).  
 
3.6 Conclusion  
 
The aqueous phase transfer of colloidal InP/ZnS quantum dots using small 
hydrosoluble thiols was studied. The deprotonation of the thiol function by an appropriate 
adjustment of the pH of the aqueous phase to slightly basic values is important to obtain 
strong binding of the ligand molecules to the NCs’ surface. Using this approach cysteine 
and penicllamine-capped InP/ZnS NCs with a colloidal stability of several weeks in water 
or buffer solution have been obtained. They combine a low hydrodynamic diameter 
(<10nm) and potentially low non-specific binding in biological environment due to their 
zwitterionic coating. The developed strategy can be applied for a large variety of QDs and 
NPs whose surface atoms have an affinity for thiolates. The formation of cysteine dimer, 
cystine, has been shown to be at the origin of the significant decrease of the PL efficiency 
of phase-transferred cysteine-capped InP/ZnS QDs. This phenomenon can be avoided by 
addition of the reducing agent TCEP during the transfer reaction, and in the best cases more 
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than 90% of the initial fluorescence intensity can be retained. The obtained hydrosoluble 
InP/ZnS NCs have a high potential for biological labeling in both in vitro and in vivo 
experiments. 
 
3.7 Experimental Section 
 
3.7.1 Materials 
D-penicillamine, L-cysteine, thioglycolic acid (98%), 11-mercaptoundecanoic acid (95%), 
tetramethylammonium hydroxide (97%), phosphate buffered saline solution (1X PBS), 3-
mercaptopropanoic acid (99+%), and tris(2-carboxyethyl)phosphine hydrochloride solution 
(0.5M), were purchased from Sigma-Aldrich and used as received. Dihydrolipoic acid was 
synthesized from thioactic acid following a literature procedure.  
 
3.7.2 Titration of ligands 
3.269 g of tetramethylammonium hydroxide pentahydrate was dissolved in 35 mL of 
degassed MilliQ water (18 MΩ) to prepare a 0.5 M base solution. In a clean glass vial (with 
cap) 0.2 mmol (Table 3.3) of the ligand is dissolved in 1 mL degassed MilliQ water and the 
solution is titrated by slowly adding the base solution (10 µL steps) and measuring the pH 
by a pH meter each time. During the titration, the ligand solution is constantly stirred (at 
~200 rpm). 
Ligand
Exact weight
(mg[µL])  
DHLA 43.1 
Cys 23.9 
Pen 30.0 
TGA 18.0[13.9] 
MPA 21.2[17.4] 
MUA 43.6 
 
Table 3.3:  Amount of ligand used during the titration. The same quantities of ligand in 1 mL of 
water (0.2 M solution) have been used for the phase transfer  
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3.7.3 Phase transfer of QDs 
 
3.7.3.1 Purification 
Thorough purification of the initial QDs, enabling the removal of excess hydrophobic 
ligands is crucial for successful phase transfer. 5 mL of the QDs in organic solvent are 
mixed with anhydrous ethanol (1:3) and centrifuged at 11200 g (g-force) for 2 minutes. The 
clear solution of supernatant is discarded and the precipitate is redispersed in 15 mL of 1:3 
chloroform:ethanol mixture and centrifuged again. The precipitate is dispersed in a 
minimum amount of chloroform. The concentration is estimated from the first excitonic 
peak in the UV-Vis spectrum.  
 
3.7.3.2 Phase transfer 
A 0.2 M solution of the ligand is prepared in 1 mL of degassed MilliQ water (18 MΩ) (cf. 
Table 3.3) and the pH is adjusted to the value specified in Table 3.1 by drop-wise addition 
of 0.5 M tetramethylammonium hydroxide. This solution is mixed with 1.5 mL (~5 µM) 
dispersion of QDs in chloroform. The biphasic mixture is stirred vigorously at ~1400 rpm 
for 2 h.  
 
3.7.3.3 Phase transfer in presence of TCEP 
The same procedure as before is applied with the difference that the ligand solution is 
constituted of 500 µL of a 0.2 M solution of the transfer ligand and 100 µL of a 0.5 M 
TCEP solution, mixed with 1 mL of ~5 µM dispersion of QDs in chloroform. 
 
3.7.3.4 Work up 
Depending on the nature of the initial ligands on the QDs surface in organic media, at the 
end of the reaction the biphasic mixture can result in the clear separation of two phases or 
in an emulsion. In the latter case, the mixture is centrifuged at lower speed (4,032 g) for 1 
min to obtain a clear phase separation. The QDs in the (upper) aqueous phase are separated 
from the (lower) organic phase. 
 
3.7.3.5 Purification and storage 
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Method A 
200 µL of the QDs in water are centrifuged in a Millipore centrifugal filter from VWR 
(MWCO 30k) at 11,200 g for 2 min. 200 µL of 1X PBS buffer (pH 7.4) or MilliQ water are 
added to the pellet and the QDs are redispersed in 200 µL 1X PBS buffer or MilliQ water 
(pH ~7) and stored in a fridge (~4°C). The typical storage concentration is ~10 µM.  
 
Method B 
A Nap5 size exclusion column from GE-Biosciences is vertically clamped.  It is 
equilibrated by running ~10 mL of 1X PBS buffer which corresponds to the three refills of 
the column. The buffer is allowed to completely enter the gel bed by gravity flow. 500 µL 
of QDs in water are added to the equilibrated column the allowed them be absorbed by the 
gel bed. ~900 µL of 1X PBS buffer is added from the top of the column and the QDs 
coming out from the bottom as drips are collected in a vial.  
 
3.7.3 Recovery of fluorescence by addition of TCEP 
600 µL of a ~6 µM dispersion of freshly transferred cysteine-capped InP/ZnS NCs at pH 9 
are mixed with 100 µL of a 0.5 M TCEP solution. 
 
3.7.4 Synthesis of InP/ZnS NCs 
730 nm emitting 
The synthesis of 730 nm emitting InP/ZnS NCs is discussed in chapter II. 
 
610 nm emitting 
 
 The 610-nm emitting InP QDs were synthesized following the procedure of Xu et. al. [45] 
with slight modification. Precisely, 0.087 g (0.3 mmol) of indium acetate, 0.130 g (0.3 
mmol) of zinc undecynelate, 0.144 g (0.6 mmol) of hexadecylamine and 0.088 g (0.3 
mmol) of stearic acid are mixed in 9 ml (36 mmol) of 1-Octadecene (ODE) in a 50 mL 
three necked flask.  The mixture is heated to ~120°C to obtain a clear solution. The flask is 
then degassed for 1 h under vacuum (~3. 10-2 mbar). During this step the solution is stirred 
magnetically at 600 rpm. Separately, 0.154 g (1.74 mmol) of P(TMS)3 in 0.5 mL of ODE is 
prepared in glove box. The flasks containing Indium precursor is backfilled with Argon and 
the P(TMS)3 solution is injected at 280°C and kept 240°C for 20 minutes. For ZnS shell 
growth: 0.95 g (1.5 mmol) of zinc stearate and 0.012 g (0.37 mmol) of zinc stearate in 3 
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mL of ODE are added to the solution. The flask is degassed for 30 minutes and backfilled 
with argon and then the solution is heated at 230°C for 20 minutes. QY: 30% in hexane. 
 
660 nm emitting 
 
660-nm emitting QDs were prepared using the same protocol as 610 nm emitting InP/ZnS, 
except that in situ generated PH3 gas was used instead of P(TMS)3 as the phosphorous 
precursor. 0.087 g (0.3 mmol) of indium acetate, 0.130 g (0.3 mmol) of zinc undecynelate, 
0.144 g (0.6 mmol) of hexadecylamine and 0.088 g (0.3 mmol) of stearic acid are mixed in 
9 ml (36 mmol) of 1-Octadecene (ODE) in a 50 mL three necked flask.  The mixture is 
heated to ~120°C to obtain a clear solution. The flask is then degassed for 1 h under 
vacuum (~3. 10-2 mbar). During this step the solution is stirred magnetically at 600 rpm. 
Separately, Separately, 0.19 g (0.6 mmol) of fine powdered Zn3P2 is weighed and degassed. 
Both the flasks are backfilled with Argon. The temperature of flask B is increased to 
250°C.  10 mL of 1M H2SO4 solution is injected to the flask A to generate phosphine gas 
and the gas is carried to the flask B by a strong flow of Argon. Within 2 minutes, the 
solution turns reddish black. Under constant Ar flux, the reaction was continued for 1h. QY 
in hexane: 12%. 
 
3.7.5 Synthesis of other types of QDs. 
 
The synthesis of other types of QDs followed reported protocols and were carried out by 
other members of the laboratory: CdSe/CdS core/shell nanorods [46], CdSe rods [47], 
CdSe/CdS/ZnS core/shell/shell NCs [48], tetragonal CuInSe2 [49] and CuInS2/ZnS 
core/shell NCs [44]. 
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4.1 Introduction 
 
This chapter focuses on the application of InP/ZnS NCs in biological imaging. The 
first section (4.2), presents the in vitro and in vivo studies performed with the NIR emitting 
InP/ZnS NCs in aqueous medium following a phase transfer (cf chapter III) from organic 
medium in which they where synthesized by the phosphine gas method described in chapter 
II. The second part of this chapter (section 4.3) presents  the results from collaborative 
works on dual modality probes [1] involving InP/ZnS NCs conjugated to gadolinium 
complexes, which act as magnetic resonance imaging (MRI) contrast agent. The objective 
is to combine fluorescence imaging and MRI within one probe and to overcome the 
shortcomings of each separate modality. Finally, in section 4.4 the possibility of 
functionalizing InP/ZnS NCs with specific copies of straptevidin protein based on their 
electrophoretic mobility will be discussed. Colloidal nanoparticles (NPs) capped with 
charged molecules move toward the opposite electrode in gel electrophoresis. It was 
originally shown by Alivisatos’ group that Au NPs conjugated with different numbers of 
DNA strands moved differently in agarose gel forming discrete bands, which allowed the 
authors to control the number of DNA per particles by separating the bands formed in 
agarose gel [2]. This technique has been the basis of various works on CdSe/ZnS 
functionalized with specific number of proteins and antibodies for targeted single molecule 
assay [3, 4]. We address the prospect of controlling the functionalization of InP/ZnS NCs 
with a known number of streptavidin molecules. 
 
4.2 Biological studies of NIR emitting InP/ZnS NCs 
 
4.2.1 Quantum dots preparation 
 
NIR emitting InP/ZnS NCs (emission: 730 nm) were phase transferred into aqueous 
medium by using penicillamine as the transfer ligand (cf. chapter III). The NCs were 
thoroughly purified by using centrifugal filters from VWR (MWCO 30-50k) to remove 
excess ligands and dispersed in PBS (pH 7.4).The hydrodynamic diameter of the NCs in 
PBS measured by DLS was 7.5±1.7 nm (Fig. 4.1a). The Figure 4.1b shows the UV-Vis and 
PL spectra of the NCs in water. 
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Figure 4.1 a) Hydrodynamic diameter of penicillamine capped InP/ZnS NCs in 1X PBS buffer 
measured using DLS. Multiple measurements (6 times) were performed and the mean value was 
calculated. The inset shows the structure of the capping ligand: penicillamine (b) UV-Vis and PL 
spectra of penicillamine capped InP/ZnS NCs in water. 
 
4.2.2 Cytotoxicity studies of penicillamine-capped InP/ZnS NCs 
 
The cytotoxicity of the penicillamine capped InP/ZnS NCs in 1 X PBS buffer (pH 
7.4) was assessed for Chinese hamster ovary (CHO) cells. The MTT assay was used to 
evaluate cytotoxicity after incubating the cells (60000/well) in presence of the quantum 
dots for 24 hours. 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl-tetrazolium bromide (MTT) 
is reduced to purple colored formazan dye following enzymatic reaction (Scheme 4.1). As 
this reaction takes place only in the living mitochondria, the amount of formazan formed is 
proportional to the number of living cells.  
 
 
 
Scheme 4.1 Conversion of the tetrazolium salt MTT into formazan dye in presence of mitochondrial 
reductase. 
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Fig. 4.2 shows the cell viablility in presence of different amounts of penicillamine capped 
InP/ZnS NCs. Even after 24h of exposure (Temperature: 37°C) at a concentration of 20 
nmol QDs/106 cells (1µM QD concentration) a significant mitochondrial metabolic activity 
with >90% cell viability was observed. Increasing the concentration to 100 nmol/106 cells 
(5µM QD concentration) reduced the cell viability to about 80%. The cell viability with 
saponin (Fig. 4.3) a molecule which is highly toxic to CHO cells [5] is plotted for 
comparison. 
 
 
 
Figure 4.2 MTT assay: cell viability after 24 hrs of incubation with 1 µM and 5 µM of penicillamine 
capped InP/ZnS NCs and 0.1% (w/v) saponin.  
 
 
Figure 4.3 Chemical structure of saponin. 
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4.2.3 Functionalisation of penicillamine-capped InP/ZnS NCs with 
maurocalcine and in vitro studies. 
 
4.2.3.1 Cell penetrating peptide: maurocalcine 
 
Cell penetrating peptides (CPPs) [6] have special properties to penetrate cell 
membranes and transport different cargoes ranging from small drug molecules to polymers 
and nanoparticles into cells [7]. There is a growing interest in transporting nanoparticles 
into cell by means of a cell penetrating peptide; the reason for this is essentially twofold: 
first, due to a large surface area and possibility to graft functional biomolecules covalently 
on to the surface, it is a potential candidate for use as a vector for the intracellular delivery 
of drugs, genes, contrast agents etc. [8]. Second, due to the unique properties of 
nanoparticles, especially the fluorescent quantum dots, the CPP-QD conjugate serves as an 
imaging and sensing tool. Maurocalcine (MCa) is a cell penetrating peptide (CPP) 
constituted of 33 amino acids (Figure 4.4). It was originally isolated from Scorpio maurus 
palmate [9]. One of its various forms has a free terminal thiol group (N-terminal) coming 
from cysteine residue, which can be attached to cargoes including nanoparticles.  
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Figure 4.4 (a) A still photograph of Scorpio Maurus palmus [10] (b) Structure of Maurocalcine with 
terminal cysteine group. (c) MCa translocating a cargo into the cell.  
 
4.2.3.2 In vitro studies  
 
MCa conjugation to the nanocrystals’ surface was achieved by incubating the 
quantum dots in a solution containing an approximately 10-fold molar excess of MCa. The 
grafting of MCa on the NCs was evident in FTIR.  The characteristic amide I (at 1665 cm-1) 
and amide II peaks (at 1522 cm-1) of the peptide bond in maurocalcine were clearly 
identified (Fig. 4.5) in the  purified MCa capped NCs sample. The amide I band arises due 
to the stretching of peptide C=O bond while the amide II is attributed to the bending of the 
adjacent N-H bond. The purification using centrifugal filters with a cut-off of 50 kDa (cf. 
experimental section) assures removal of free MCa (3.8 kDa) and penicillamine (0.15 kDa) 
molecules. Absorption at 2922 cm-1 and 2858 cm-1 are attributed to saturated –CH3 
stretching which are present in both maurocalcine and penicillamine.  
 
 
 
Figure 4.5 a) FTIR spectra of penicillamine capped InP/ZnS NCs, of MCa, and of MCa grafted 
on InP/ZnS NCs b) Peptide bonds responsible for the characteristic amide I and amide II bands 
in FTIR spectra.  
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The purified MCa-functionalized quantum dots (5µM) were used for incubation with CHO 
cells (~120000 cells/well) in culture (2 hrs). Fig. 4.6 demonstrates successful cell 
penetration of the MCa-modified quantum dots, whereas no penetration was observed with 
Pen being the only surface ligand. These results confirm that MCa is indeed bound to the 
nanocrystals’ surface and that it retains its cell-penetration properties upon conjugation.  
 
 
 
 
Figure 4.6 Confocal microscopy images of Chinese hamster ovary (CHO) cells showing 
successful cell penetration of maurocalcine capped InP/ZnS QDs (incubation time: 2 hrs). Image 
size: 100x100 µM. (a),(b) penicillamine-capped QDs; (c),(d) maurocalcine-functionalized QDs; 
(a),(c) without excitation; (b),(d) excitation at 480 nm; quantum dots in green (false colors). 
 
The mechanism by which cell translocation occurs has been a subject of debate. There are 
evidences of both direct membrane translocation [11] and endocytosis [12] in the literature. 
In addition, a co-existence of both pathways has also been suggested recently [13]. Studies 
of the fate of NCs cell post-penetration with transmission electron microscopy could 
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unravel this in our case. Depending upon the mode of internalization the NCs may end up 
in different compartments of the cell which can be investigated under TEM. For example, if 
the uptake of the NCs by cells takes place via endocytosis, the NCs may end up in late 
endosomes while the direct translocation of NCs leads to accumulation of NCs in 
cytoplasm or nucleus [14]. Further, the study of the cell penetration behavior of InP/ZnS 
NCs functionalized with Maurocalcine in the presence of an inhibitor of endocytosis could 
be equally interesting for understanding the mechanism of penetration [15]. Another 
common way to assess the involvement of endocytosis is decreasing the incubation 
temperature to 0-4°C which inhibits all energy-dependent pathways. Decreasing the 
incubation temperature could be applied to block the endocytosis process [16] and then 
study the other forms of translocation taking place, if any. Nonetheless, the observation in 
our case that only maurocalcine functionalized InP/ZnS NCs was internalized by cell while 
penicillamine capped InP/ZnS NCs was not strongly suggests that a) maurocalcine is 
attached to NCs and retains its cell penetrating properties and b) penicillamine capped 
InP/ZnS NCs alone were not uptaken by cells by any of the internalization modes, be them 
phagocytotic or non-phagocytotic. This inference is also very interesting because, the 
phagocytotic uptake of nanoparticles by a cell is highly dependent on cell types, nature of 
the ligand and size of the particles among other factors. In particular, zwitterionic ligands 
coated NCs have shown high resistance to endocytotic uptake by cells compared to NCs 
with charged ligands. For example, the quantities of zwitterionic CdSe/CdZnS QDs 
adsorbed on or internalized by HeLa cells were comparable to those of the control sample 
with no QDs whereas high internalization was observed with positively and to a lesser 
extent with negatively charged QDs [17].  
 
4.2.4 Biodistribution of penicillamine-capped NIR emitting InP/ZnS NCs in 
mice 
 
There is a growing interest in understanding the pharmacokinetics of the different 
types of nanoparticles injected intravenously or by other routes of injection as it directly 
concerns the fate of the nanoparticles in the body and their possible accumulation in organs 
[18-22]. The biodistribution of the II-IV QDs in vivo have been extensively investigated 
[18, 19, 23], however little is known about III-V QDs, especially InP/ZnS NCs. We studied 
the biodistribution of InP/ZnS NCs coated with zwitterionic penicillamine in mice after tail 
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vein injection. By selecting the emission of InP/ZnS in near infrared region (650-900 nm) 
we sought to minimize the autofluorescence, scattering and absorption of photons by the 
tissue components. Further, zwitterionic penicillamine is expected reduce the non-specific 
binding of the NCs with serum proteins which has been recently observed in vitro [24]. The 
non-specific binding of serum proteins leads to increase in hydrodynamic diameter of the 
NCs complicating the clearance mechanism [25]. Moreover, negatively charged NCs may 
favor adsorption of plasma opsonins and trigger phagocytosis, a natural response of the 
immune system when encountering foreign bodies such as nanoparticles [26]. The 
phagocytosis-mediated uptake by macrophages, white blood cells, may end up in the 
organs of the reticulo-endothelial system (RES) such as the liver, spleen, and bone marrow 
[27]. 100 µL of the QDs solution (12 µM) was injected intravenously (IV) into the tail of 
nude female mice of 4-5 weeks of age and the biodistribution was followed directly by 
fluorescence imaging. Fluorescence imaging provides qualitative and semi-quantitative 
information of the quantum dots in vivo and can be applied to study the biodistribution of 
quantum dots in animals by directly exploiting their fluorescence properties [19, 20, 27]. 
Figure 4.7a shows the temporal evolution of the fluorescence signal emanating from the 
injected InP/ZnS NCs during 24 hrs. Within 1-3 hrs of injection, the fluorescence signals 
were detected in kidney and liver. Even after 24h of injection high fluorescence signal was 
observed in mice indicating the excellent stability of these NCs. The dominant signals in 
kidney and liver were also observed in the organs after dissection (Fig. 4.7b). As already 
mentioned, it was previously shown that only small (< 6 nm) zwitterionic-coated QDs 
could be efficiently eliminated by renal clearance, while larger nanoparticles are known to 
accumulate in the organs of the RES [28]. Taking into account the hydrodynamic diameter 
and the size distribution of the QDs used here (7.5±1.7 nm), our results suggest those with 
smaller hydrodynamic size ended up in the kidneys while the larger ones were uptaken by 
the RES and accumulated in liver and spleen. Besides, weak fluorescence was also detected 
in the lungs of one of the two mice investigated. The nanoparticles uptaken by the RES are 
known to enter intestine after hepatobiliary processing (HB) [22]. However, in our case the 
fluorescence signal detected in the stomach and intestine was similar to that of the healthy 
Nude mice without injection. This comes from the standard mouse feed alfalfa, which 
fluoresces in the near infrared part of the spectrum. No fluorescence was detected in other 
organs such as the heart and the brain. Based on fluorescence signals of the organs, an 
image treatment using ImageJ software resulted in the histogram presented in Figure 4.7c.  
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Figure 4.7 (a) Evolution of the fluorescence signal in a nude mouse after the injection of 730 
nm emitting penicillamine coated InP/ZnS NCs in 1x PBS buffer. Excitation 640 nm, Exposure 
time: 10 ms (K=kidney, L=liver, I=intestine). (b) Ex vivo fluorescence analysis of the organs 
24h after tail vein injection. Excitation wavelength: 640 nm, Exposure time: 200 ms. (c) 
Histogram showing the comparative fluorescence signals in organs without injection (control) 
and after intravenous (IV) injection. The error bars represent the standard deviation for the two 
animals. 
 
4.2.5 Conclusion 
NIR emitting InP/ZnS NCs coated with penicillamine in 1X PBS buffer (pH 7.4) 
show low cytotoxicity for CHO cells with a cell viability of over 90% for a concentration 
of 20 nmol per 106 cells and about 80% at QD/cells concentration 100 nmol per 106. Due to 
high affinity of ZnS surface to thiolated ions, these QDs could be easily functionalized with 
maurocalcine, a cell penetrating peptide containing terminal cysteine group. The InP/ZnS 
NCs attached to the MCa show excellent cell penetration behavior in CHO cells in direct 
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contrast to pencillamine capped InP/ZnS NCS. Finally, the NIR emitting penicillamine 
capped InP/ZnS NCs were injected in mice intravenously and their biodistribution was 
followed by fluorescence imaging.  The fluorescence detected in the kidneys, liver and 
spleen suggests that the NCs may have been partially uptaken by the RES (bigger 
particles), while the smaller particles accumulated in the kidneys enabling renal clearance. 
 
4.3 Dual modality probes: grafting of MRI contrast agent to 
fluorescent InP/ZnS NCs 
 
4.3.1 Introduction 
 
A new class of imaging agents called dual modality probes combines two different 
types of imaging techniques yielding more information than can be harnessed using each 
method separately. For example, magnetic resonance imaging (MRI) has excellent 
anatomical resolution; however, it suffers on the molecular level from its intrinsic low 
sensitivity [1]. Fluorescent based probes on the other hand with excellent molecular level 
sensitivities have generally poor spatial resolution and penetration depth. To address this 
issue we combine the two modalities in a single imaging agent. In this section, grafting of 
this MRI contrast agent on the surface of fluorescent InP/ZnS NCs and MRI studies in mice 
are presented. 
 
4.3.2 MRI Contrast Agent 
 
Lanthanide ions are used in a wide range of biomedical applications as contrast agents. The 
high spin paramagnetism (S=7/2) and the slow electronic relaxation of gadolinium (Gd) 
ions make them ideal candidate for use as contrast agents in magnetic resonance imaging 
(MRI). Gd(II) complexes are often favored over iron oxide particles as the former increases 
both the longitudinal (denoted by 1/T1) and transverse relaxation (1/T2) rates of water 
molecules present in the vicinity to a differing extent depending on the nature of the ligand 
and the magnetic field compared Iron oxide particles which generally increases 1/T2 
relaxivity. In addition, Gd complex affect bulk magnetic susceptibility of the tissues to a 
lesser extent, thereby minimizing the artifacts [29]. In our studies a picolinate based Gd 
complex was used. This complex containing two picolinate arms and one acetate arm 
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appended to 1,4,7-tri-azacyclononane core have greater stability (logKGdL=15.8) as 
compared to Gd complex of analogous ligands such as 1,4,7-triazacyclononane-N,N’,N”-
triacetic acid (logKGdL=13.7) [29]. Moreover, higher selectivity of the complex to Gd 
ions over Ca ions (logKCaL=8.18) makes them suitable for biological studies [30].  
The complex (Gd-2) whose molecular structure is presented in Fig. 4.8 was prepared by 
Graeme Stasiuk and Marco Giardello in collaboration with Marinella Mazzanti and Daniel 
Imbert from CEA/INAC/SCIB/RICC.  
 
 
Figure 4.8 Gd complex (GD-2) used for grafting on InP/ZnS NCs. GD-2 was synthesized by a 
coupling reaction between GD-1 and thioactic acid, using the coupling agent 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide (EDCI) and a catalyst 4-Dimethylaminopyridine (DMAP).  
 
4.3.3 Grafting of Gd complex with InP/ZnS NCs 
 
The grafting of the Gd complex (Gd-2) on the InP/ZnS-pen NCs was achieved by 
anchoring the complex via dithiol group from thioactic acid substituent. Tris(carboxyethyl) 
phosphine (TCEP) is used to cleave the disulfide bond directly in situ. As the reducing 
ability of TCEP is compromised at higher pHs, only slightly basic pH (~9) was maintained 
to facilitate thiolate formation and drive the ligand exchange process. To a mixture 
containing the QDs and 200 fold molar excess of Gd complex, a 9000 fold molar excess of 
TCEP is added and followed by vortexing (800 rpm) for 12 hrs at room temperature. The 
large amount of TCEP ensures the cleavage of the disulfide bond facilitating the grafting of 
dithiols on the ZnS shell. 
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Figure 4.9 Grafting of the Gd complex (GD-2) on penicillamine capped InP/ZnS NCs via in situ 
generated dithiol groups. 
 
The first evidence of successful grafting comes from the increase of the mean 
hydrodynamic diameters from 6.9±1.3 nm for the penicilamine capped InP/ZnS NCs (610 
nm emitting) to 8.6±1.5 nm for the Gd complex functionalised InP/ZnS NCs. Second, the 
nuclear magnetic resonance dispersion (NMRD) profile of the purified sample showed a 
marked increase in relaxivity, r1 at around 35 MHz as compared to the free Gd complexes 
(Figure 4.10). The Gd complexes (GD-1 and GD-2) follow a classic profile for mono aqua 
chelates, with high relaxation rate (r1) at low fields 0.01 to 1 MHz, showing a decrease in r1 
between 1- 10 MHz until a plateau is reached (10 - 35 MHz). The Gd complex grafted to 
QD shows intriguingly different profile, with an increase in r1 from 3 to 35 MHz of 10 to 
13 mM-1 s-1. The intensity of MRI signal depends on the relaxivity of water protons. For 
example with increase in r1 the MRI signal increases [29]. The presence of Gd-complexes 
improves the MRI signal by increasing the relaxivity (r1) of the surrounding water 
molecules. The increase in r1 in presence of a Gd(III) complex essentially depends on both 
the properties of the complex as well as the applied magnetic field. In NMRD experiments 
we measure the dependency of the relaxity with magnetic field; however the profile will 
also be affected by the changes in the properties of the complex in the presence of QDs. 
The properties of complex that affect relaxivity (r1) of water protons which are either 
directly coordinated to the Gd ions (called inner coordination sphere) or away in the outer 
coordination sphere or beyond that (called bulk solvent) are (a) hydration number, q (b) the 
distance between the water proton and the unpaired electron spin of the Gd(III) ions, r (c) 
the rotational correlation time, Rτ  (d) the water exchange rate, mτ   i.e. the rate of water 
exchange between the water molecule directly coordinated to the Gd(III) ions and the water 
present in the bulk solvent and (e) the electronic relaxation time, T .The significant 
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increase in r1 is attributed to the slower rotation of the complex in the presence of QDs. 
This effect have been observed when Gd (III) chelates bound to proteins, such as Human 
serum albumin (HSA) shown by caravan et al. [29]. The increase in r1 indicates that a Gd 
(III) chelate is bound to a large particle such as the QD; confirming its grafting. From 35 - 
200 MHz there is a loss of r1 from 13 – 4 mM-1s-1, this is standard for T1 contrast agents at 
higher field. At 200 MHz the effect of increased mass is lost so the grafted QD appears to 
have a similar relaxation rate per Gd molecule to that of the Gd complex alone. The 
relaxivity (r1) for Gd complex grafted on the QDs at 35 MHz is 12.64 mM-1 s-1 (Table 4.1). 
It is interesting to note that this is only the relaxivity per Gd complex. By determining the 
concentrations of QDs and Gd complex in solutions respectively by UV-Vis spectroscopy 
and magnetic susceptibity measurements the number of Gd complexes per QD was 
calculated to be around 70. Consequently, the relaxivity per QD is calculated to be around 
900 mM-1 s-1. 
 
 
Figure 4.10. NMRD profile for GD-1(blue), GD-2 (black) and GD-3 (red) measured at 298K on a 
Spinmaster FFC (fast field cycling) NMR relaxometer. 
 
Sample Relaxivity ( r1 at 35 MHz) 
Gd1 4.13 mM-1 s-1 
Gd2 4.58 mM-1 s-1 
Gd3 12.64 mM-1 s-1 
 
Table 4.1: relaxivity at 35 MHz 
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4.3.4 MRI studies with Gd picolinate grafted to InP/ZnS NCs 
 
Figure 4.11a-b compares the MRI images of rat brain injected with Gd-1 (left hemisphere) 
and the Gadolinium complex 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid, 
Gd-DOTA (right hemisphere) at 30 minutes and 282 minutes. Gd-DOTA is a class of 
macrocyclic MRI contrast agents used in clinical practice. Gd-1 on the left shows an 
increased tissue retention time up to 280 minutes compared to Gd-DOTA (about 60 min), 
which is a major advantage for obtaining better resolved images over a prolonged period of 
time. Figure 4.11c-d shows the MRI images obtained under the same conditions with Gd-2 
grafted on InP/ZnS NCs (Gd-3). As in the case of Gd-1 alone, we can see that GD-3 has 
also a long tissue retention time, as it can be easily detected after 282 min. Figure 4.11e 
directly compares the MRI signal vs. time for the free Gd-complex (Gd-1) and the Gd-
complex grafted to QDs (Gd-3). These images have been taken at high field (7T), showing 
that the attachment to the QD provides excellent contrast as a high field agent. In addition, 
the fluorescence properties of the InP/ZnS NCs (emission: 610 nm) grafted with Gd 
complex make them an attractive dual modal contrast agent. Figure 4.11f shows the 
fluorescence excitation and emission spectra of the Gd-complex functionalised InP/ZnS 
NCs. 
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Figure 4.11 MRI images of a rat brain acquired at 7 Tesla a) Gd-1 at 30 minutes, b) Gd-1 at 282 
minutes, injected into the left hemisphere of the brain, coinjected with Gd DOTA in the right 
hemisphere. C) Gd-3 at 30 minutes, d) Gd-3 at 282 minutes, injected into both hemispheres of the 
brain. e) Graph showing the MRI signal vs. time (retention time), (7T) f) excitation (left) and 
fluorescence spectra of InP/ZnS NCs functionalised with the Gd-complex (Gd-3). For the PL 
spectrum, the excitation wavelength is 320 nm. 
 
4.3.5 Conclusion 
 
It has been shown that picolinate based lanthanide chelates bearing a dithiol group can be 
grafted to InP/ZnS NCs, creating a dual mode contrast agent with r1=900 mM-1s-1 per QD 
and the PL emission at 610 nm. MRI studies performed on rat brains with Gd 
functionalized InP/ZnS QDs show a significantly increased retention time.  
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4.4 Functionalisation of InP/ZnS NCs with a controlled number of 
protein molecules. 
 
4.4.1 Introduction 
 
The fluorescence properties of InP/ZnS QDs coupled with the possibility to graft 
biomoleucles on their surface makes these NCs excellent candidates for various biological 
applications including single-molecule imaging in living cells [31]. However, the lack of 
the precise control of the number of functional molecules results in undesirable effects such 
as increased hydrodynamic diameter, multivalency and nonspecificity [3]. One way of 
controlling functionalisation is based on the movement of gold nanoparticles or QDs 
conjugated with high molecular weight functional molecules such as proteins [4], 
oligonucleaotides [2] and polyethylene glycols [32]. For examples, it has been shown that if 
the molecular weight of the molecule (e.g. polyethylene glycols) is roughly ≥ 5000 g mol-1, 
the difference between monofunctional and bi or higher functional gold nanoparticles can 
be detected as discrete bands on the agarose gel [32], which can be isolated. Similar 
observations have been reported for nanocrystals/DNA conjugates [2]. The electrophoretic 
separation has been recently applied to conjugate only one copy of straptevidin with single 
biotin binding site (monovalent) to QDs [3]. While literature examples are available for 
CdSe/ZnS QDs, gold nanoparticles, no studies have been reported for InP/ZnS NCs. Here 
we present functionalisation of InP/ZnS NCs with maleimide-activated straptevidin (SAV-
mal), by combining conjugation with gel purification. This work has been carried out in 
collaboration with Samuel Clarke and Maxime Dahan at Laboratory Kastler Brossel (ENS 
Paris), who brought in their expertise in peptide and protein functionalisation of QDs. 
 
The functionasation of InP/ZnS QDs can be divided into the following three steps: 
Step I: Functionalisation of InP/ZnS NCs with a thiol rich peptide to form peptide coated 
NCs (pQDs)  
Step II functionalisation of the pQDs with streptavidin (SAV) and 
Step III Electrophoretic separation of SAV conjugated pQDs by analyzing the discrete 
bands formed on the agarose gel based on stoichiometries of SAV and pQDs  
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4.4.2 Step I: Functionalisation of InP/ZnS QDs with peptides 
 
Phytochelatin-based peptides with 20 amino acids units were selected for this study 
following literature reports of their use as a capping peptide, especially with CdSe/ZnS 
NCs [4, 33]. The chosen peptide is rich in thiol groups due to the presence of 6 cysteine 
residues. The reason for this choice is two fold: first, the thiol group can be used for 
binding the peptide covalently with NCs surface and secondly, the free thiol groups present 
on the surface can be further utilized for attaching other functional molecules by using 
cross linkers such as succinimidyl 4-(N-maleimidomethyl) cyclohexane-1-carboxylate 
(SMCC) which contains a thiol reactive maleimide group and an amine-reactive N-
hydroxysuccinimide (NHS). The peptide also has a short polyethylene glycol (PEG) 
segment to reduce nonspecific interactions. The hydrophobic InP/ZnS NCs in toluene are 
directly coated with peptides using a standard protocol [33]. InP/ZnS NCs in toluene are 
mixed with a large excess of peptides in a pyridine/dimethyl sulfoxide (DMSO) co-solvent 
and increased the pH of the medium to initiate the ligand exchange reaction. The column 
purified pQDs were highly soluble in distilled water and common physiological buffers. 
However, a drawback of this approach is the strongly reduced fluorescence intensity of the 
InP/ZnS QDs upon treatment with pyridine and DMSO. Therefore, we explored an 
alternative to the aforementioned method. It consists of the phase transfer of the InP/ZnS 
NCs to the aqueous medium (cf. Chapter 3) and subsequent incubation of the water soluble 
NCs with the peptide in basic pH as in the case of the functionalisation with MCa and Gd-
picolinate. Fig. 4.12a shows the gel electrophoresis (GE) of the InP/ZnS NCs phase 
transferred with three different ligands namely penicillamine (Sample A), thioglycolic acid 
(B) and 11-mercaptoundecanoic acid, MUA (C). As the method of monofunctionalisation is 
based on the migration of bands in gel electrophoresis, it is important that the starting QDs 
have a well defined single band. NCs with a high zeta potential such as MUA coated ones 
were found to be suitable as confirmed by gel electrophoresis after peptide functionaliation 
(Fig. 4.12c).  
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Figure 4.12: Migration of (a) Penicillamine capped InP/ZnS NCs, sample A, thioglycolic capped 
InP/ZnS NCs , sample B and 11-Mercaptoundecanoic capped InP/ZnS NCs, sample C after 5 
minute. b) MUA capped InP/ZnS NCs c) The GE of the MUA capped InP/ZnS NCs (QD), MUA 
capped InP/ZnS NCs after incubation with peptide at basic pH (pQD crude) and purified peptide 
coated InP/ZnS NCs (pQD purified). 
 
4.4.3 Step II: functionalisation of InP/ZnS pQDs with streptavidin 
 
We selected streptavidin (SAV) protein because of its very high affinity for biotin. The 
selective streptavidin - biotin interaction is one of the strongest non-covalent interactions 
known and have been employed in a large number of nanoparticle related works. As shown 
in Figure 4.13, when SAV is reacted with four fold excess of the cross linker (SMCC), a 
fraction of its amino groups reacts with the succinimide groups of SMCC to form 
maleimide activated SAV (SAV-mal). In a second step, the SAV-mal is grafted on the 
pQDs via reaction between free thiol groups of the pQDs and the thiol-reactive part of the 
maleimide to form SAV coated InP/ZnS NCs (InP/ZnS-SAV).  
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Figure 4.13: a) Scheme for the conjugation of the biomolecules to pQDs. Maleimide-activated 
streptavidin (SAV-mal) is formed by reaction of SMCC with streptavidin. In a second step, SAV-
mal is covalently conjugated to the pQDs by reaction of free thiol groups in the cysteine residues. (b) 
Gel electrophoresis (GE) of pQDs conjugated to increasing amounts of SAV.  
 
4.4.4 Step III: Electrophoretic separation 
 
The ratio SAV-mal:pQDs is varied from 0 to 20 and the conjugates (InP/ZnS-SAV) migrate 
correspondingly to the different obtained stoichiometries in agarose gel (Fig. 4.14). 
InP/ZnS-SAV1 containing one SAV protein are isolated by cutting the gel. Size exclusion 
chromatography (SEC) is used to confirm the monofunctionality. The SEC was calibrated 
using a set of protein standards of known molecular weight and hydrodynamic diameter. 
For the 600 nm emitting InP/ZnS, the hydrodynamic diameters of the InP/ZnS pQDs and 
InP/ZnS-SAV1 are respectively 9.4 and 10.5 nm. Similarly for the 650 nm emitting QDs 
the diameters are 12.5 to 13.3 nm confirming the monofuntionality as well as the compact 
nature of the obtained conjugates.  
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Figure 4.14: a) Gel electrophoresis (GE) of 650 nm emitting InP/ZnS pQDs conjugated to 
increasing amounts of SAV. Discrete bands represent pQDs with N=O, 1 or ≥2 copies of SAV. B) 
GE of 600 nm emitting InP/ZnS pQDs conjugated to increasing amounts of SAV c) GE of 
monofunctional, SAV-conjugated pQDs (InP/ZnS-SAV1) after their purification from the crude 
mixture. The monofunctional pQDs retain the N=1 position in the gel, indicating good stability of 
the isolated conjugate. d) Size exclusion chromatography (SEC) of streptavidin (SAV) (elution at 9.8 
ml, Dh=4.8 nm), 600 nm emitting monofunctional InP/ZnS SAV1 (8.1 ml, 10.5 nm), multifunctional 
InP/ZnS-SAV (7.8 ml, 11.7 nm), 650 nm emitting InP/ZnS-SAV1 (7.5 ml, 13.3 nm) and InP/ZnS-
SAVm (7.3 ml, 14.5 nm) 
 
4.4.5 Conclusion 
 
This section demonstrates that by employing a simple concept that nanoparticles coated 
with different stoichiometries of high molecular weight molecules such as streptavidin, 
monofunctionalised InP/ZnS NCs can be prepared. These monofunctional NCs with 
compact size and controlled number of active sites have potential application in various 
biological imaging experiments, including single molecule imaging. 
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4.5 Experimental 
 
4.5.1 MTT assay 
 
4.5.1.1 Preparation of 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl-tetrazolium bromide 
(MTT) stock solution 
The 12 mM MTT stock solution was prepared by a standard procedure. 5 mg of MTT was 
dissolved in sterile PBS (pH 7.4) by sonication and then the clear solution is stored at 4oC 
in dark.  
4.5.1.2 Cell viability 
Primary cultures of Chinese hamster ovary (CHO) cells were seeded into 96 well micro for 
24h. The next day, the culture with CHO cell density of approximately 60000 cells/well 
were incubated for 24 hrs at 37°C with 100 µL of 1 µM QDs, 5 µM QDs and 0.1% (w/v) 
saponin. Control wells containing cell culture medium with cells, without QDs addition, 
were included in each experiment.  The medium in the well is removed and replaced with 
100 µL of fresh culture medium. 10 µL of stock solution of 3-(4, 5-dimethylthiazol-2-yl)-2, 
5-diphenyl-tetrazolium bromide (MTT) was added to each well and incubated for 4 hours. 
The formed formazan crystals were dissolved by adding 50 µL of DMSO to each well and 
the optical density of the colored solution was measured at 540 nm using a microplate 
reader (Biotek ELx- 800, Mandel Scientific Inc.) for quantification of the living cells 
 
4.5.2 Functionalisation of penicillamine capped InP/ZnS NCs with Maurocalcine 
 
300 µL (0.5µM) of QDs in distilled water are mixed with 2 mg of MCa in 400 µL of borate 
buffer. pH is adjusted to ~9 by addition of NaOH. The mixture is allowed to incubate for 
12h at room temperature. The sample is then thoroughly been purified with centrifugal 
filters from VWR (MWCO 50kDa) via centrifugation at 2,800 g (2 times) for 4 minutes.  
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4.5.3 Cell penetration experiment 
 
200 µL (5 µM) of the MCa-functionalized quantum dots and penicillamine capped InP/ZnS 
NCs were used for incubation with CHO cells (120000 cells/well) in culture (2 hrs). After 
two hours the cells were washed with 1X PBS for 3 time and the cells were imaged using a 
confocal microscope. 
 
 
 
4.5.4 Biodistribution of InP/ZnS NCs in mice  
 
Two healthy mice (female swiss nu/nu, 2 months old) were anesthetized and each was 
injected intravenously with 100 µL of 12 mM penicillamine capped InP/ZnS NCs 
(emission: 730 nm) in 1 X PBS (pH 7.4). The injected mice were placed on a warm 
chamber (37.5 °C) connected to an anesthesia mask (isoflurane/air 1.5%) and  imaged with 
a Xenogen IVIS Lumma at 5 minutes, 1 hour, 3 hours and 24 hours. The software used to 
drive the set up was Living Image® 3.0. For the mouse imaging excitation wavelength of 
640 nm was used with exposure time set at 10 ms.  After 24 hours the mice were sacrificed 
and the organs were imaged under the same condition, except the exposure time was set at 
200 ms. All the animal experiments were performed in agreement with the EEC guidelines 
and the “Principles of Laboratory Animal Care” (NIH publication no. 86-23, revised 1985). 
Semiquantitative data for the biodistribution was obtained using imageJ software from the 
fluorescence images by drawing regions of interest (ROI) on the area to be quantified. For 
calculations, the lower and upper intensities were set at 250 and 14000 counts respectively. 
 
4.5.5 Functionalisation of InP/ZnS NCs with Gd-complex  
 
QD dispersions (0.5 mL, 5.2 x 10-6M), Gd-2(0.247 mL, 2.1 x 10-3M) and TCEP (0.046 mL, 
0.5 M) in degassed water, is combined and the pH adjusted to 9 by adding NaOH (0.5 M). 
The mixture is shaken at 800 rpm overnight at room temperature. 200 µL of the QDs in 
water are centrifuged in a Millipore centrifugal filter from VWR (MWCO 30k) at 11,200 g 
for 2 min. 200 µL of 1X PBS buffer (pH 7.4) or MilliQ water are added to the pellet and 
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the QDs are redispersed in 200 µL of 1X PBS buffer or MilliQ water (pH ~7) and stored in 
a fridge (~4°C).  
 
4.5.6 In vivo MRI studies 
 
MRI experiments were performed in collaboration with Cathy Poillot and Michael 
Dewaard at Neurosciences institute. All the experiments were conducted in agreement with 
the “Principles of Laboratory Animal Care” (NIH publication no. 86-23, revised 1985). The 
guidelines of the French Ministry of Agriculture (87/848) and of the European community 
(86/609/EEC) were also respected. The protocol was submitted for approval to the local 
Neuroscience institute committee to minimize animal suffering and abusive use of animal 
numbers. OFA 7 week-old rats were anesthesized by 5% isoflurane inhalation in a mixture 
air/O2 30%, and maintained in anaesthesia in 2% isoflurane. Rats were then injected with 
10 µM of 1 mM Dotarem or GD-3 or GD-1 in the striatum using a stereotaxic frame 
(coordinates: 0 mm frontal, 3.5 mm lateral, and 5.5 mm in depth) and at a rate of 2mL/min. 
T1 images of the rat brain were acquired 15 min after striatum injection and after placing 
the rats in a 7T magnet (Bruker BioSpec 70/20 USR AVIII). Sequences of 16 images of 
slice depths of 1 mm each over a period of 15 min were taken. This sequence was repeated 
over 4 hrs period, thus leading to the total acquisition of 16 sets of 16 images. The 
temperature was maintained at 37°C throughout the experiments. 
 
4.5.7 Monofunctionalisation of InP/ZnS NCs  
 
4.5.7.1 Synthesis of peptide coated NPs 
 
Method 1 
 
200 µL of the 1 mg/mL QD stock solution in toluene is heated to remove the solvent and 
redispersed in 450 µL of pyridine. Separately, 4 mg of the peptides (New England peptides) 
were dissolved in 50 µL of dimethyl sulfoxide (DMSO) at the ratio 60% Nterm-
KGSESGGSESGFCCFCCFCCF-Cterm and 40% Nterm-PEG12-FCCFCCFCCF-Cterm. 
Peptides and QDs solutions are mixed and 10 mL of tetramethyl ammonium hydroxide 
(TMAH, 25% w/v in methanol) was added (pH ~11). The solution immediately becomes 
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turbid and the QDs precipitate. Following centrifugation, the supernatant is discarded and 
the resulting peptide coated QDs are redissolved in 50 µL of distilled water. 
 
Method 2 
 
InP/ZnS NCs, phase transferred with 11-mercaptoundecanoic acid (cf. chapter III), were 
purified by the centrifugation method over 10 kD filter (2800 g). ~1 mg/ml stock solution 
of MUA capped InP/ZnS NCs was prepared. Separately, 4 mg of peptides (New England 
peptides) were dissolved in 300 µL in water at the ratio 60% Nterm-
KGSESGGSESGFCCFCCFCCF-Cterm and 40% Nterm-PEG12-FCCFCCFCCF-Cterm at 
pH 11. The peptides are added to the QDs solution and incubated at room temperature for 
48 hours. The quantum dots are purified using centrifugal filters from VWR (MWCO 30k) 
at 10,000 rpm for 2 minutes (two times). 
 
4.5.7.2 Monofuntionalisation of peptide coated NPs with streptavidin 
 
Maleimide-activated SAV (SAV-mal) was prepared by adding a four fold excess of 
succinimidyl 4-(N-maleimidomethyl) cyclohexane-1-carboxylate (SMCC) to 20 mM of 
streptavidin in HEPES buffered saline (HBS, 20 mM HEPES, 50 mM NaCl, pH 7.2) and 
then incubating for 30 minutes at RT. Next, SAV-mal is added to the InP/ZnS NCs coated 
with peptide (pQDs, section: 4.5.6.1) at the molar ratio of 5, 10 and 20 and incubated for 
further 30 minutes at RT (Concentrations: 1mM for pQDs and 10 mM of SAV-mal). Gel 
electrophoresis was employed to separate the pQDs conjugated with different 
stoichiometries of the SAV. 
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General conclusion  
 
We presented a method of producing near infrared (NIR) emitting InP/ZnS core/shell 
NCs for biological imaging. Using phosphine gas as a precursor and controlling the reaction 
parameters such as temperature and the amount of precursor larger sized InP NCs (> 4 nm) 
with photoluminescence in the NIR region (720-750 nm) can be reproducibly synthesized. In 
addition, as phosphine gas generation involves relatively less expensive precursors such as 
Zn2P3 (rodenticide) and sulfuric acid, this synthetic scheme is more economical than existing 
routes involving P(TMS)3. The fluorescence quantum yield of these NIR emitting InP NCs 
(<1 %) could be increased up to 18% by overcoating them with 1-2 monolayers of ZnS shell.  
Moreover, absence of the toxic elements such as Cd, As, Hg, Se etc. make these InP/ZnS NCs 
highly attractive for biological imaging applications.  
Phase transfer of InP/ZnS NCs to aqueous medium was studied with various thiol 
groups containing ligand. The deprotonation of the thiol function by an appropriate 
adjustment of the pH of the aqueous phase to slightly basic values is important to obtain 
strong binding of the ligand molecules to the NCs’ surface. Cysteine and penicillamine 
capped NCs prepared using this approach were stable for several weeks in water or buffer 
solution.  They combine a low hydrodynamic diameter (<10nm) and low non-specific binding 
in biological environment due to their zwitterionic coating. The developed strategy can be 
applied for a large variety of QDs and NPs whose surface atoms have an affinity for thiolates. 
Strong fluorescence quenching was observed in the case of  cysteine capped InP/ZnS NCs 
which is attributed to the formation of cysteine dimer, cystine. The problem has been 
addressed by either using the reducing agent TCEP during the transfer reaction or by 
substituting the molecule penicillamine which is more resistant to oxidation. NIR emitting 
InP/ZnS NCs coated with penicillamine in 1X PBS buffer (pH 7.4) show low cytotoxicity for 
CHO cells with a cell viability of over 90% for a concentration of 20 nmol per 106 cells and 
about 80% at QD/cells concentration of 100 nmol per 106. Due to high affinity of the ZnS 
surface for thiolated ions, these QDs could be further functionalized with maurocalcine, a cell 
penetrating peptide containing terminal cysteine group. The InP/ZnS NCs attached to the 
MCa show excellent cell penetration behavior in CHO cells in direct contrast to pencillamine 
capped InP/ZnS NCS. The NIR emitting properties of penicillamine capped InP/ZnS NCs 
were exploited by injecting in mice intravenously and following their biodistribution using 
fluorescence imaging.  These QDs can be potentially used as fluorescence probes for 
sensitive, multiplexed detection of surface markers on tumour cells. A gadolinium picolinate 
bearing a dithiol group were grafted on to the InP/ZnS NCs surface, creating a dual mode 
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contrast agent with high rexalivity (r1=900 mM-1s-1 per QD) and photoluminescent properties. 
MRI studies performed on rat brains showed a significantly increased in retention time, 
allowing for a non-invasive and prolonged monitoring of the area of interest. Finally, it 
was demonstrated that the number of protein molecules grafted on the QDs can be controlled 
by employing a simple concept that nanoparticles coated with different stoichiometries of 
high molecular weight molecules such as streptavidin. These monofunctional NCs with 
compact size and controlled number of active sites have potential application in various 
biological imaging experiments, including single molecule imaging.  
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ANNEXE : Instruments and techniques 
 
A.1 Ultraviolet-visible (UV-Vis) spectroscopy 
UV-Vis spectroscopy was performed on a HP 8452A spectrophotometer.  It is a single beam 
spectrophotometer operating in the wavelength range 190-820 nm using a diode array for 
detection. The background run and the sample acquisition are performed in series on the same 
cuvette holder. In the absorption spectra absorbance (dimensionless) is plotted against 
wavelength (nm). UV-visible ChemStation has been used as operating software.  For all the 
measurements, a quartz cuvette of 1 cm width has been used. UV-Vis spectroscopy forms the 
basis of quantum dot characterisation because the fundamental aspect of fluorescence is the 
absorption of photons. They have characteristic absorption onset called excitonic peak. The 
position of this peak depends on the band gap of the material and thus the size of the NCs.  
The change of intensity of light passing through a sample can be expressed in terms of optical 
density or absorbance (A) as follows: 
 A=log10(Io/I)                                                                                                                        E-A1 
 
Figure A.1. Absorption of light 
where I0 is the intensity of the light at a given wavelength λ before it enters the sample and I 
is the intensity of light that has passed through a sample (transmitted intensity). By applying 
Lambert-Beer’s law concentration of the absorbing species in the solution can be 
quantitatively determined as follows:  
l
Ac ×= ε                                                                                                                               E-A2 
where ε  is molar extinction coefficient and ε  is the path length (cm) of the sample (cuvette)  
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For colloidal semiconductor NCs the molar extinction coefficient in the equation A.2 is a size 
dependent variable. For example, the ε  of InP quantum dots is given by  
)109839.8())(105137.5()(76532)(1.3046 5523 ×−×+−= DDDε                            E-A3 
where D is the diameter (nm) of the NCs. D can be obtained either directly from TEM 
micrographs or by measuring the first excitonic peak in the UV-VIS spectrum. The relation 
between the first excitonic peak and the diameter is given by the equation A4 [1] 
1)103122.1()104550.5()100781.1()100262.1()107707.3( 12233548512 +×−×+×−×+×−= −−−−− λλλλλD
 
A.2 Photoluminescence (PL) spectroscopy 
 
Fluorescence spectra were obtained on a F-4500 spectrofluorometer (Hitachi) with a quartz 
cell of 1 cm by dispersing quantum dots in suitable solution. Except otherwise noted, all the 
measurements were performed with Instrument Parameters: 
Parameters Set  
Scan mode: Emission 
Data mode: Fluorescence 
Scan speed: 1200 nm/min 
Delay: 0 s 
EX Slit: 5.0 nm 
EM Slit: 5.0 nm 
PMT Voltage: 700 V 
Response: 2.0 s 
 
Table A.1 Instrument parameters used for PL spectroscopy 
 
The excitation wavelengths used for the measurements have been mentioned in the legend of 
the spectra. The light absorbed by quantum dots is emitted within a few nanoseconds (10-30 
ns) at a lower energy (higher wavelength). Monochromatic light of certain wavelength is 
passed through the sample. As the proportion of the incident light is absorbed by the sample, 
the light of higher wavelength is emitted. This fluorescent light then passes through a 
monochromator and reaches a detector, which is usually placed at 90° to the incident light 
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beam to minimize the risk of transmitted incident light reaching the detector. The intensity vs. 
wavelength plot obtained is referred to as the PL emission spectrum.   
 
A3 Quantum yield calculation 
 
The fluorescence quantum yield (QY) is the ratio of the number of photons emitted to the 
number absorbed.   
abs
em
photons
photons
QY =                                                                                                         E-A.4   
One way to determine the relative quantum yield of an unknown sample ( SQY ) is by 
comparing the integrated photoluminescence of the sample with that of a standard dye of 
known quantum yield ( RQY ) using the equation: 
2
2
RSR
SRS
RS nAI
nAI
QYQY ××
×××=                                                                                         E-A.5 
Where I is the integrated PL intensity, n  is the refractive index, and A is the absorbance.  
The above equation can be written a follows 
2
2
S
S
R
R
S
S
RS n
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I
A
I
QYQY ××=                                                                                              E-A.6 
If we take the multiple measurements and obtain the gradient of I vs. A. Then above equation 
E-A.6 can be written as  
2
2
S
S
R
S
RS n
n
Gradient
Gradient
QYQY ××=                                                                                    E-A.7 
Using equation E-A.7, the QY of the obtained InP//ZnS NCs were determined by comparing 
with Rhodamine 6G in ethanol (QY = 95%). Both the sample and the reference were excited 
at 480 nm and the room temperature solvent refractive indices of hexane (1.36), water (1.33) 
and ethanol (1.375) were taken into consideration. We plotted the integrated fluorescence 
intensity vs. optical density (see example in Figure A.2) and compared the slopes of the linear 
fit for the sample and the standard. 
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Fig. A.2 a) Integrated PL vs. absorbance plot for a) Rhodamine 6G (QY=95 %) and b) InP/ZnS NCs 
(calculated QY=18%) 
 
A4 X-ray diffraction (XRD) 
 
Powder X-ray diffraction was carried out using Philips X’Pert diffractometer with z Co 
source (λ = 1.789 Å, 50 kV/35 mA). Disoriented silicon was used as the substrate for the 
measurements. Rietveld refinement was performed on X’pert highscore software operated in 
semi-automatic mode. The fit had the following agreement indices: 
 
R expected 3.21573 
R profile 6.0679 
Weight R profile 6.85054 
D-statistics 0.48079 
Goodness of fit 4.53817 
 
 
 
 
The crystallite size calculated using Scherrer’s equation 
         θ
λ
cosB
KD =                                                                                                             E-A.7                                   
where K is the shape factor, λ is the wavelength of the X-ray, B is the full width at half 
maximum (FWHM) in radians, and θ is the Bragg angle. For our calculation, we use the shape 
factor of 1.1 which is a theoretical value for a perfect sphere [2].  The Scherrer formula 
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provides a lower bound on the crystallite size due to contribution of other factors (e.g. 
inhomogeneous strain and instrumental effects) to the width of a diffraction peak besides 
crystallite size.  
 
A.5 Transmission electron microscopy (TEM)  
TEM measurements were performed with JEOL 4000EX electron microscopy operated at 400 
kV. The samples were thoroughly purified prior to drop casting onto a Cu grid. Size 
distribution was analyzed using imageJ software.  
A.6 Energy dispersive X-ray spectroscopy (EDX) 
 
EDX experiments were performed on a JOEL JSM-840A scanning electron microscope 
(SEM) equipped with an Oxford Instrument energy dispersive X-ray (EDX) analyzer. The 
instrument was operated at 20 KeV. For sample preparation, a highly concentrated colloidal 
solution (~10-2 M) of colloidal NCs in chloroform was obtained. The solution was drop cast 
on a conducting silicon wafer. For better signal, thick (at least 0.5 mm) deposits were made 
on the wafer. Multiple runs (>10) were performed at various positions of the grid and the data 
are expressed as mean value with standard deviations. In EDX spectroscopy a sample is 
bombarded with a high-energy beam of charged particles such as electrons or protons or X-
rays. These charged particles may eject an electron from the  inner shell of a sample atom 
such as K, L, M creating an electron hole. An electron from any of the outer shell then fills 
the hole, releasing an energy corresponding to the differences between the two shells. In EDX 
this energy released is detected. As the energy difference between the electronic shell of the 
materials is characteristic for the nature of the atoms and hence the element. Thus, the 
presence of different elements in the sample can be detected quantitatively. 
 
A.7 Dynamic light scattering (DLS) 
 
Dynamic light scattering (DLS) is a technique for measuring what is known as hydrodynamic 
diameter of particles usually in colloidal suspension. It is based on the Brownian motion of 
colloidal particles in solution and calculated from the translational diffusion coefficient using 
Stokes-Einstein equation: 
D
kTDh πη3=                                                                                                                     E-A.8 
Where 
k = Boltzmann constant  
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T  = absolute temperature 
η =viscosity  
D = translational diffusion coefficient 
 
The hydrodynamic diameter is always bigger than the particle size measured by TEM or other 
similar techniques due to the contribution of the surrounding molecules or ions in the 
translational motion of the particles in a liquid. Further in the case of quantum dots, the 
presence of capping ligands contributes to the slowing of the Brownian motion significantly 
and hence the increase in hydrodynamic diameter. The latter can be measured as intensity 
distribution, volume distribution, number distribution or sometimes also expressed in mass 
distribution. Unfortunately, the obtained values differ significantly from one method to 
another, especially intensity distribution gives larger hydrodynamic diameter than the others 
as scattering intensity is proportional to 6)( hD  and the size obtained is more weighed towards 
larger sized particles.  However, for comparing size with microscopy techniques such as 
TEM, the number distribution is recommended [3]. The hydrodynamic diameter of the water-
soluble NCs dispersed in water was measured by dynamic light scattering (DLS), using a 
Malvern Zeta Sizer (NanoZS). The samples have been thoroughly purified with centrifugal 
filters from VWR (MWCO 30k) and dispersed in MilliQ water (18 mΩ) prior to the 
measurements. Given the sensitivity of the instrument, multiple runs (> 3) were performed to 
avoid erroneous results. The spectra have been corrected by the instrument software for 
viscosity (0.882 mPa.s at 25°C), absorption (at 532 nm), solvent (water) refractive index 
(1.33) and material (InP) refractive index (3.1). The data is collected in automatic mode and is 
expressed in number-percent. 
 
A.8 Nuclear magnetic resonance (NMR) 
 
Proton and carbon NMR spectra were recorded on Brüker DPX200 instruments using 
standard Brüker software. The 1/T1 measurements were performed by Graeme Statiuk at 
CEA/INAC Grenoble on a Brucker Avance 200 spectrometer (200MHz). The NMRD profiles 
were measured at 298K in the range 0.1 and 35Mz, by using a Spinmaster FFC (fast field 
cycling) NMR relaxometer.  
 
A.9 Circular dichroism 
Chirality measurements were performed in Chirascan CD spectropolarimeter. Penicillamine 
capped InP/ZnS NCs were passed through Nap 5 size exclusion columns from GE-
biosciences and dispersed in 1X PBS buffer prior to measurements. 
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A.10 Size exclusion chromatography 
 
SEC of the peptide coated InP/ZnS QDs (pQDs) was performed by Samuel Clarke at 
LKB/ENS Paris on an Agilent 1200 series HPLC system with a TSKG4000SW colum (Tosoh 
Bioscience) and a mobile phase of borate buffer (10 mM borate, 50 mM NaCL, pH 7.5). 
(Flow rate: 0.5 mL/min). Following injection of 20 mL of sample, the absorption and 
fluorescence were detected online during the elusion. The hydrodynamic diameter (Dh) of the 
pNPs was determined from their peak elution volume and comparison with a standard curve, 
which was obtainedfrom a set of protein standards (Biorad) of known molecular weight and 
Dh: thyroglobulin (669 kDa, 17 nm), gammaglobulin (158 kDa, 11 nm), ovalbumin (44 kDa, 
55 nm), myoglobin (17 kDa, 3.8 nm) and vitamin B-12 (1.4 kDa, 1.5 nm) 
 
A.11 Gel electrophoresis (GE) 
 
GE was performed on 1% agarose (sigma) gels in 0.25X TAE buffer (10mM Tris, 10 mM 
acetate, 0.25 µM EDTA, pH 8.3), 25 µL of pNPs (and pNPs conjugated with SAVs) were 
mixed with 2 % glycerol and then loaded into the wells of the gel. 10 V cm-1 electric field was 
applied for 30 minutes. The band was extracted using a razor and loaded into a 0.2 µm 
centrifugation filter (Pall). After centrifugation at 5000 g for 5 minutes, the pure QDs were 
eluted with 0.25 TAE and stirred at 4oC. 
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Abbreviations 
 
CD: circular dichroism 
CHO: Chinese hamster ovary (cells) 
CIS:  copper indium sulphide 
CPP: cell penetrating peptide  
Cys: cysteine 
Dh: hydrodynamic diameter  
DHLA: dihydrolipoic acid 
DMAP: 4-Dimethylaminopyridine 
DMF:    dimethylformamide DLS: dynamic light scattering 
DMSO: dimethyl sulfoxide 
DNA: Deoxyribonucleic acid 
DOTA: 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid 
DTT: dithiothreitol  
EDCI: 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide  
EDX: energy dispersive X-ray spectroscopy 
FTIR : Fourier transform infrared (spectroscopy)  
FWHM: full width at half maximum 
Gd-DOTA: 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid 
HB: hepatobiliary processing  
HDA: hexadecylamine 
HAS: human serum albumin 
1H NMR: proton nuclear magnetic resonance 
HOMO: highest occupied molecular orbital 
InP: indium phosphide 
kDa: kiloDalton 
MA: myristic acid 
MCa: maurocalcine  
MPA: 3-mercaptopropanoic acid 
MRI: magnetic resonance imaging 
MTT: 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl-tetrazolium bromide  
MUA: 11-mercaptoundecanoic acid 
NCs: nanocrystals 
NHS: N-hydroxysuccinimide  
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NIR: near infrared  
NMR: nuclear magnetic resonance 
NMRD: nuclear magnetic resonance dispersion 
NPs: nanoparticles  
ODE : 1-octadecene 
PBS : phosphate buffer saline  
PEG: polyethylene glycol 
Pen: penicillamine  
PL : photoluminescence  
P(TMS)3: tris(trimethylsilyl)phosphine 
pH : potentia hydrogenii  
PEG : polyethylene glycol 
QDs: quantum dots 
QY : quantum yield 
RES: reticulo-endothelial system 
rpm: rotaion per minute 
SAMs: self assembled monolayers  
SAV: streptavidin  
SEC: size exclusion chromatography 
SMCC: 4-(N-maleimidomethyl) cyclohexane-1-carboxylate  
TCEP : tris(2-carboxyethyl) phosphine hydrochloride  
TEM : transmission electron microscopy 
TGA : thioglycolic acid 
TMAH: tetramethylammonium hydroxide  
UV : ultra violet 
UV-Vis : ultra violet-visible 
XRD: X-ray diffraction  
 
 
                      
 
 
 
 
Title: Synthesis and functionalisation of near infrared emitting nanocrystals for biological imaging. 
Summary  
This thesis concerns the development of near infrared (NIR) emitting InP/ZnS core/shell nanocrystals for 
biological imaging. In situ generated phosphine gas was used as the phosphorous precursor, indium myristate as 
the In precursor and 1-Ocadecene as the solvent to produce InP NCs with emission in the range of 720-750 nm. 
Growth of 1-2 monolayers of a ZnS shell on the surface of the InP NCs strongly improves their quantum yield.  
Next, we studied the phase transfer of the obtained InP/ZnS NCs to aqueous medium with various thiol group 
containing ligands. Emphasis is put on the colloidal stability and the retention of fluorescence quantum efficiency 
during the transfer. Zwitterionic ligands such as pencillaime and cysteine have been studied in view of their 
biological interest in providing compact size and reduced non-specific interaction with cells.  
The cytotoxicity of pencillamine capped InP/ZnS NCs has been evaluated in cell culture. The NIR emitting 
properties of the QDs have been exploited to their study bio-distribution in mice by fluorescence imaging. In 
addition, functionalisation of the InP/ZnS NCs with a cell penetrating peptide, with a MRI contrast agent 
(gadolinium complex) and  with a controlled number of streptavidin molecules have been explored to demonstrate 
the large interest of InP/ZnS NCs in biology. 
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Titre: Synthèse et fonctionnalisation de nanocristaux émettant dans le proche infrarouge pour l’imagerie 
biologique 
Résumé : 
Cette thèse concerne le développement de nanocristaux (NCs) cœur/coquille d’InP/ZnS émettant dans le proche 
infrarouge pour l'imagerie biologique. Dans la synthèse chimique des NCs cœur d’InP, nous avons utilisé la 
phosphine générée in situ comme précurseur de phosphore en combinaison avec le myristate d’indium comme 
précuseur d’indium et l’1-octadécène comme solvant. Les NCs obtenus sont hautement cristallins et présentent une 
fluorescence dans la gamme 720-750 nm, selon leur taille. La croissance d’une ou deux monocouches  (coquille) 
de ZnS sur la surface des NCs d’InP a considérablement amélioré leur rendement quantique de fluorescence.  
Nous avons de plus étudié le transfert de phase de ces NCs InP/ZnS du milieu organique au milieu aqueux en 
utilisant diverses molécules hydrophiles contenant un groupe thiol. En particulier, nous nous sommes intéressés au 
transfert de phase avec des molécules zwitterioniques tels que la penicillamine et la cystéine afin d’obtenir une 
taille hydrodynamique compacte, et de réduire les interactions non-spécifiques en milieu biologique. Dans l’étude 
du transfert de phase, l'accent a été mis sur la stabilité colloïdale des NCs et sur la préservation de leur efficacité de 
fluorescence en milieu aqueux.  
 
La cytotoxicité des NCs InP/ZnS fonctionnalisés avec la pencillamine a été évaluée en culture cellulaire. Puis la 
bio-distribution de ces NCs a été étudiée dans des souris vivantes par imagerie de fluorescence grâce à leur 
émission dans le proche infrarouge. Pour finir, les fonctionnalisations de NCs InP/ZnS d’une part avec un peptide 
de pénétration cellulaire, d’autre part avec des agents de contraste IRM (complexes de gadolinium) et enfin avec 
un nombre contrôlé de molécules  streptavidine ont été explorées, démontrant le grand intérêt de ces NCs pour 
l’imagerie biologique. 
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